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ABSTRACT
ROLE OF HOST RESTRICTION FACTORS ON PORCINE REPRODUCTIVE AND
RESPIRATORY SYNDROME VIRUS (PRRSV) REPLICATION
PRATIK KATWAL
2022
In this study, the role of IFITM3 on PRRSV replication was studied in vitro by
expressing exogenous IFITM3 in MARC-145 cells. An average of 31% reduction in
PRRSV N protein expression and an average of 5.4 fold decrease in virus titer in the
supernatant were observed in IFITM3 overexpressing cells as compared to vector control
cells at 24 hours post infection (hpi). Moreover, there was a positive correlation between
interferon- induced IFITM3 up-regulation and reduced PRRSV replication. To determine
the role of endogenous IFITM3 in PRRSV replication, siRNA induced knockdown of
IFITM3 was employed. RT-PCR validated the successful silencing of IFITM3 in MARC145 cells, with an average knockdown of 50%. PRRSV RNA copies were 1.28-fold
higher in IFITM3 silenced cells as compared to control silencing, suggesting that
knockdown of endogenous IFITM3 only slightly enhanced PRRSV replication. Taken
together, these results suggest antiviral role of IFITM3 against PRRSV in vitro. In this
study, we tested if the antifungal drug Amphotericin B restores PRRSV replication in
IFITM3 overexpressing MARC-145 cells. Amphotericin B only partially restored
PRRSV replication as confirmed by flow cytometry. Interestingly, more colocalization of
PRRSV with early endosome marker was observed at 3 hpi (37.9%) than at 1 hpi (23.8%)
and 6 hpi (31.8%). To further investigate the stage of PRRSV infection restricted by
IFITM3 over-expression, colocalization study was performed at 3 and 24 hpi. Our results
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showed that IFITM3 expressing cells were positive for PRRSV at both 3 and 24 hpi. The
percentage of IFITM3 positive cells with positive PRRSV staining was significantly
higher at 3 hpi as compared to 24 hpi. Collectively, our data suggest that IFITM3 may
restrict PRRSV via multiple post-entry mechanisms.
The role of restriction factor, ZMPSTE24, on PRRSV replication was also
studied. The ZMPSTE24 exerted antiviral effect against PRRSV as confirmed by both
ZMPSTE24 overexpression and silencing experiments. A reduced expression of PRRSV
N protein by approximately 3% and a 146-fold decrease in virus titer in the supernatant in
the ZMPSTE24 overexpressing cells compared to vector control were observed. To
further determine the role of endogenous ZMPSTE24 in PRRSV replication, we
performed siRNA induced silencing of ZMPSTE24 in MARC-145 cells. RT-PCR
validated highly successful silencing of ZMPSTE24, with an average knockdown of
74%. Knockdown of endogenous ZMPSTE24 slightly affected PRRSV replication, as
only 1.2 fold increase in PRRSV RNA copies was observed. To study the stage of
PRRSV infection impeded by ZMPSTE24, colocalization study was performed at 3 and
24 hpi. There were no significant differences in the number of PRRSV positive cells or
total viral RNA copies between the vector control and ZMPSTE24 over-expressing cells
at 3 hpi. The colocalization of PRRSV with ZMPSTE24 was significantly higher at 3 hpi
as compared to 24 hpi, suggesting that ZMPSTE24 does not affect PRRSV entry into
endosomes and restriction occurs after 3 hpi. Taken together, our results suggest that
IFITM3 and ZMPSTE24 likely restrict PRRSV at multiple post-entry steps.
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Chapter 1: Literature Review
1.1 An overview of Porcine Reproductive and Respiratory Syndrome Virus
(PRRSV)
1.1.1 PRRSV genome, structure, and replication
Porcine reproductive and respiratory syndrome virus (PRRSV) belongs to the
family Arteriviridae in the order Nidovirales [66]. Within this order, the family
coronaviridae is also included. In contrast to the coronaviruses family, the known
members of the Arteriviridae, which includes PRRSV, equine arteritis virus, and three
other members, show narrow host range and commonly infect a single animal species
[66, 161]. PRRSV is an enveloped virus, spherical or oval shaped, with a positive (+)
sense, single stranded RNA (ssRNA) genome [32, 90]. It has a diameter of 45-65 nm and
accommodates the nucleocapsid (N) protein that is about 20-35 nm in diameter [32]. The
molecular weight of N protein is about 15 kDa and anti-N monoclonal antibodies (mAbs)
have been shown to recognize both the conserved and variable epitopes within the
PRRSV N protein [32, 98, 161]. The North American and European strains were
identified using the anti-N (mAb) [161]. The PRRSV RNA genome is approximately 15
kb in length and contains eleven open reading frames (ORFs) of which the replicase
associated ORF1a and b are the largest and encode the viral polymerase [90]. The
replicase associated polyproteins pp1a and pp1ab are encoded by the ORFs 1a and 1b and
are translated from the genomic mRNA [90]. These polyproteins are subsequently
processed to produce 14 non-structural proteins (nsps). The ORF1a encodes
transmembrane (TM) domains. The RNA-dependent RNA polymerase (RdRp) is
encoded by the ORF1b [90]. On the other hand, the subgenomic mRNAs from the ORFs
2-7 encode the minor envelope proteins (GP2a, GP3, GP4, E, and ORF5a), major
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envelope proteins (GP5 and M), and the nucleocapsid protein (N) [66]. Therefore, eight
structural proteins are encoded by the subgenomic mRNAs [66]. The mature nonstructural proteins synthesized from the pp1a and pp1ab polyproteins assemble to form
the replication and transcription complex (RTC) which leads to the synthesis of full
length complementary minus (-) strand by the viral RdRp [38, 66]. The continuous (-)
strand synthesis serves as a template for genome replication while the discontinuous (-)
strand synthesis serves as a template for the synthesis of subgenomic mRNA [38]. The
PRRSV non-structural proteins nsp2 and nsp7 have been show to localize to the
perinuclear region in the area of endoplasmic reticulum which forms modifications
leading to the double membrane vesicles (DMVs), the site for assembly of the RTC [38,
66, 103]. The PRRSV genome is packaged within the nucleocapsid (N). During the
process of budding, PRRSV becomes enveloped and is then released from the cell by
exocytosis.
1.1.1.1 An overview of PRRSV receptor and entry factors
Several studies attempted to identify the principal receptor for PRRSV attachment
and entry [127]. Early studies indicated that the intermediate filament protein, vimentin
may be an important factor in PRRSV attachment and entry [19, 71]. Vimentin is
expressed on the MARC-145 cells and anti-vimentin antibody inhibited PRRSV entry
and subsequent infection [71]. Also, expression of simian vimentin protein rendered nonpermissive cells susceptible to PRRSV. However, these studies did not conclusively
demonstrate the role of vimentin in supporting productive virus replication. Another
important candidate in the search for PRRSV receptor was porcine sialoadhesin (CD169).
Sialoadhesin is a membrane glycoprotein in the siglec family of sialic acid binding lectins
[144]. Monoclonal antibody against sialoadhesin blocked PRRSV infection in porcine
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alveolar macrophage (PAM) [33]. Transfection of the non-permissive PK-15 cells with
porcine sialoadhesin enabled virus internalization. However, no productive virus
replication could be observed due to block in the virus fusion step [135]. Also, heparan
sulfate was found to be an important factor in PRRSV entry. However, both sialoadhesin
and heparan sulfate are not expressed on MARC-145 cells [33]. Eventually, CD163,
belonging to the scavenger receptor cysteine-rich (SRCR) superfamily was identified as
the principal receptor for PRRSV [19]. CD163 is principally expressed in the
differentiated macrophages, with low level of expression in undifferentiated cells [19, 37,
111, 144]. In this regard, its aberrant expression in MARC-145 cells renders these cells
susceptible to PRRSV [144]. Transfection of CD163 cDNA in the non-permissive cell
lines such as the baby hamster kidney (BHK-21) cells not only rendered them susceptible
to PRRSV infection, but also resulted in productive virus replication [19].
The SRCR family of proteins recognizes a wide variety of ligands and functions
as pattern recognition molecules by binding to various bacterial and viral pathogens [37,
144]. CD163 is a type 1 transmembrane protein consisting of nine highly conserved
extracellular domains, each consisting of about 110 amino acids, also called SRCR
domains [37, 144]. CD163 expressed in macrophages has been best characterized as a
receptor that binds the hemoglobin-heptaglobin complex, thereby clearing these
complexes by endocytosis [37, 46, 48]. This protects tissues from oxidative damage that
could potentially result from the free hemoglobin released by lysis of red blood cells [48].
CD163 is a group B SRCR protein and consists of eight cysteine residues per domain,
with the exception of domain eight. The loop 5-6 region of the SRCR 5 has been shown
to be highly conserved across different mammalian species [144]. The SRCR 5 domain
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has been shown to be the main site of interaction with PRRSV for infection [132, 144].
Expression of CD163 on porcine macrophages has been shown to correlate with infection
with African Swine Fever Virus [110]. CD163 recycles between plasma membrane and
endosome, unlike the sialoadhesin CD169 which is mainly expressed at the plasma
membrane. CD163 colocalizes with PRRSV in the early endosomes and PRRSV
interaction with both CD169 and CD163 has been shown to be important in the infection
of PAMs [130, 131]. Non-permissive cells co-expressing CD169 and CD163 were shown
to have enhanced virus infectivity as compared to cells expressing CD163 alone [130].
Therefore, CD169 is the internalization receptor while CD163 is critical for virus
uncoating within the endosomes.
1.1.1.2 Receptor mediated endocytosis
Initial attachment of PRRSV membrane (M) protein to the heparan sulfate
molecules on PAMs is followed by virus internalization [28]. This occurs through
interaction of PRRSV GP5/M proteins with sialoadhesins which leads to the
internalization of PRRSV into clathrin-coated vesicles [96, 129]. The receptor mediated
endocytosis is dependent on the interaction of PRRSV with CD163 which occurs within
the early endosomes [19, 131]. This leads to the uncoating of PRRSV within the acidic
(low pH) environment. Studies have suggested that the process of PRRSV entry into
endosomes and subsequent uncoating in MARC-145 occurs in a manner similar to PAMs
[73]. The endosomes are characterized by unique pH; as virus trafficking occurs through
early endosome to late endosome, there is a progressive increase in acidity of the
organelles. Early endosomes have a pH of 6-6.5, while late endosomes and lysosomes
have pH values in the range of 5-6 to 4.6-5 respectively [131]. Treatment of PAMs with
bases such as NH4 Cl and chloroquine was shown to block virus uncoating as viruses were
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trapped within the vesicles, indicating that virus uncoating requires fusion with low pH
endosomes [96]. The Rab family of small GTPases are often used as markers for the
identification of endosomes. These proteins are important in the regulation of the
endocytic pathways, chiefly clathrin-coated-vesicle- mediated transport [152]. Rab5 and
its effector, early endosome antigen (EEA1) can be used to study the colocalization of
PRRSV within early endosomes [131]. Late endosomes/lysosomes are characterized by
the LAMP-1 marker. In primary alveolar macrophages, colocalization of PRRSV was
observed with the EEA1 marker. However, little or no colocalizaton was observed with
the LAMP-1 marker [131]. These findings suggest that entry of PRRSV may occur
through early endosomes.
1.1.1.3 pH dependent fusion of viruses within the endocytic pathway
Viruses whose fusion in the endosomes is dependent on pH are most sensitive to
IFITM mediated restriction. IFITM proteins, chiefly IFITM2 and IFITM3 are located
within early and late endosomes and restrict viruses within these compartments by
inhibiting fusion of host cell membrane with the virus membrane [121]. IFITM has been
tested against several viruses for its antiviral activity and majority of these viruses are
enveloped. As viruses are trafficked through the endocytic pathway, they encounter
progressively acidic environments within the low pH endosomes [121]. IFITM3 has been
shown to inhibit West Nile virus, vesicular stomatitis virus, etc. that fuse at pH greater
than 6. These viruses are inhibited within the early endosome, which has a pH varying
between 6 to 6.5 [47, 121, 142]. On the other hand, Influenza virus, Dengue virus, etc.
that fuse at pH below 6 are inhibited by IFITM3 within the late endosomes where the pH
varies between 5-5.5 [16, 57, 121]. IFITM1 is expressed mainly at the plasma membrane
and has been shown to inhibit viruses whose fusion is independent of pH, or whose
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fusion is further upstream of the endocytic pathway where the pH is notably higher [83,
92]. Therefore, IFITMs restrict several enveloped viruses at different stages of cellular
trafficking. The fusion mechanism of most of these viruses is triggered at a specific pH.
These findings suggest that in general, IFITM mediated restriction is imposed at the stage
of cellular entry. This is consistent with findings of several studies which suggest that
IFITM directly or indirectly interferes with cell-virus fusion and a number of models
have been proposed to explain the mechanism of IFITM mediated virus restriction [104].
1.1.2 PRRSV infectivity
PRRSV exhibits very narrow host range and pigs are the only known natural host
of PRRSV. PRRSV shows very restricted tropism in the natural host, infecting cells of
the monocyte lineage, principally the fully differentiated porcine alveolar macrophages
(PAMs) [19]. In cell culture, the African green monkey kidney cells MA-104 and its
derivate, MARC-145 cells are fully susceptible to PRRSV, supporting productive virus
replication [19, 70]. Besides these cell lines, PRRSV has also been reported to infect
VERO cells and CL-2621 [12, 74, 118]. However, although VERO cells support
successful attachment and internalization similar to MARC-145 cells, they do not support
successful virus replication [74]. At present, MARC-145 cells are the most commonly
used cell line for PRRSV propagation and infectivity studies in vitro [19, 90].
1.1.3 Clinical signs, pathogenesis, and transmission
In the beginning, PRRSV was identified as a pathogen causing reproductive
disease in gilts and sows and respiratory disease in young pigs. Initially, it was reported
to have caused outbreaks in North America and Western Europe [68, 161]. Clinical
diseases due to PRRSV infection include anorexia, still born, early farrowing, and
abortion [68, 161]. However, clinical outcomes have been reported to vary among herds
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and in general lead to subclinical infections [161]. Nursery pigs infected with PRRSV
often show chronic disease along with secondary bacterial or viral co-infections [161].
Studies have shown that fetuses are susceptible to PRRSV during the whole gestation
period [25, 32, 68, 161]. Congenital PRRSV infections have been shown experimentally
[32, 161]. Reproductive loss and infertility in sows is an important characteristic of the
disease. Although fetuses of the PRRSV inoculated sows remain susceptible throughout
the entire gestation period under experimental conditions, exposure of sows to PRRSV in
the field leads to reproductive failure in the late gestation period [68, 76, 161]. This has
been show to correlate well with the presence of the macrophages in the endometrium
and placenta that express the principal PRRSV receptor, CD163, in addition to
sialoadhesin [68]. Therefore, transplacental infection is reported mostly in the late
gestation period due to PRRSV replication in the target cells. Intranasal inoculation of
sows with PRRSV results in efficient replication of PRRSV in the respiratory tract,
leading to viremia that then eventually spreads to the endometrium and placenta, thereby
causing apoptosis of cells during the late gestation period [68].
PRRSV infection can be divided into three stages: acute infection, persistence,
and extinction [90]. In the acute stage, PRRSV principally infects macrophages in the
respiratory tract. Typically, viremia occurs at 12 hours post infection [90, 161]. Although
gross lesions are only observed occasionally in the lungs of experimentally inoculated
animals, microscopic lesions have been reported in lungs, lymph nodes, and blood
vessels. In the persistence stage, viremia subsides along with the absence of the obvious
signs of clinical disease. Virus replication mainly occurs in the lymphoid organs at this
stage, thereby leading to increased spread of virus via oral-nasal secretions [90]. In the
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extinction phase, virus is completely cleared off, which may take up to 250 days after
infection [90]. Overall, the degree and extent of the clinical respiratory disease could be
affected by the age of the infected animal, virulence of the PRRSV strain, and the
antibody dependent enhancement of infection [149, 161]. The presence of sub-optimal or
sub-neutralizing antibodies against PRRSV leads to exacerbation of the disease outcome
in the infected animals [161]. The presence of cross-reactive antibodies in the animals
enhances the infection by increased uptake of virus by macrophages and has been
demonstrated under experimental conditions [149, 161].
Two genotypes of PRRSV are known. The North American genotype appeared in
the late 1980s and this was followed by the European genotype which appeared in the
early 1990s [145]. There is only about 55-70% nucleotide similarity between the two
genotypes [2, 97]. PRRSV has a high degree of transmissibility [11, 161]. Most of the
swine producing areas of the world today have reported PRRSV infection, with global
distribution spanning across North America, Europe and Asia [30, 161]. Serological
studies showed that PRRSV entered the swine population in Iowa in the mid 1980s, and
increase in prevalence of PRRSV was reported each year thereafter [11, 161]. PRRSV
causes severe respiratory disease in young pigs and reproductive failure in sows [90].
Depending on the PRRSV strain, pigs in some farms showed subclinical infections, while
other farms showed severe respiratory or reproductive disease in pigs [90]. Also, the
emergence of highly pathogenic PRRSV strains has caused significant economic loss to
the pork industry not only in North America, but also in Europe and Asia [53, 67, 93,
128]. Several experimental studies have shown that PRRSV can play important role in
porcine respiratory disease complex and is often responsible for exacerbating the
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pulmonary disease conditions when co-infection with other bacterial or viral pathogens
occurs [21]. The suppression of immune response by PRRSV has also been well studied,
which may explain the susceptibility of the host to infection with other secondary
bacterial or viral pathogens.
The dominant neutralizing epitope has been shown to be located in the PRRSV
GP5, along with identification of epitopes on both M and GP4 proteins [89, 100, 133].
PRRSV glycoprotein cluster GP2a-GP3-GP4 interacts with the principal receptor CD163
during infection [27]. Suppression of interferon production in cells infected with PRRSV
due to its interference with the IFN components is one of the major factors responsible
for the delayed antibody response. PRRSV may antagonize the IFN response by
inhibiting the IFN regulatory factors (IRFs) whose activation is critical for the IFN
activity [90]. Likewise, glycan shielding masks the neutralizing epitopes, thereby
allowing evasion of the antiviral response [89]. The N-glycans in both GP5 and GP3 have
been shown to be important in impeding the neutralizing antibody response [36, 137].
PRRSV strains differ in their N glycosylation patterns [36]. These may also lead to
persistence of virus in pigs [89].
PRRSV is a highly infectious virus, requiring very low infectious dose to produce
infection in the animal host [161]. PRRSV is very sensitive to external environment as it
is an enveloped virus. It is generally a labile virus and is inactivated rapidly at
temperatures above 37o C [32, 105]. Although aerosol formation has been suggested to be
the primary route of virus transmission, it has been very difficult to demonstrate aerosol
transmission under experimental conditions [161]. On the other hand, several studies
have shown PRRSV transmission by direct contact [32]. Acutely infected animals are
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reported to infect other animals by direct contact. These animals can transmit virus for up
to 15 weeks post infection [161]. In nursery pigs, direct contact may be a major route of
PRRSV transmission [32].
1.2 Innate immunity
1.2.1 A brief overview of Interferon response
Interferons play a crucial role in the control of virus infection. Upon infection of
cells, the interferon pathway is activated which then alarms the cells of foreign invasion
[109, 126]. This eventually leads to the clearance of pathogens. The early description of
interferon reported the role of a newly identified substance that inhibited influenza virus
infection [58]. Further studies identified interferons as small proteins produced by cells
upon recognition of the pathogen [80]. The innate immune sensors, called pattern
recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs)
expressed on microbes. This begins a cascade of signaling leading to IFN production
[115]. Interferons are grouped into three different classes and are defined based on their
receptor complexes. There are three interferon types and each type is known to perform
distinct functions within cells. The most commonly studied IFN in regard to antiviral
immunity are the Type I and Type II IFNs [115]. Moreover, while many viruses induce
IFN response in infected cells, some viruses interfere with IFN and downregulate IFN
synthesis as a means of evading antiviral immunity.
1.2.1.1 Summary of the three classes of Interferon
Type I interferon in humans consists of IFNα, IFNβ, IFNε, IFNĸ, and IFNω.
These interferons signal through binding to the IFN alpha receptor 1 and 2 heterodimer
(IFNAR1 and IFNAR2) [109, 115]. The Type I IFN receptors are expressed on most
nucleated cells [56]. Although most cells can produce and respond to IFNα and IFNβ, the
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predominant IFN alpha producing cells are the plasmacytoid dendritic cells [87, 115].
IFNɤ is the only known member of the type II IFN family whereas the most recently
discovered type III IFN includes a number of members, principally the IFN λ1, IFN λ2,
and IFN λ3, and a recently identified IFN λ4 [56, 115]. Type II interferons act through
the IFN gamma receptor heterodimer (IFNɤ1 and IFNɤ2) while type III interferons act
through the low affinity receptor subunit, interleukin 10 receptor 2 (IL-10R2); and the
high affinity receptor subunit, IFN λ receptor 1 (IFNLR1) heterodimer [56, 115]. Type II
IFN receptors have a broad tissue distribution and most cell types respond to type II IFN.
The IFN gamma is mainly produced by immune cells [109]. In contrast, the type III IFN
receptor IFNLR1 is mainly restricted to the epithelial cells as a result of which many cell
types respond poorly to type III IFN [56].
1.2.1.2 An overview of Interferon signaling
Upon binding to their respective receptor complexes, the signaling of Type I and
Type III interferons converge at the STAT1/STAT2 phosphorylation [115]. Briefly,
phosphorylation and activation of Janus Kinase JAK1 and Tyrosine Kinase (TYK2) in
the cytoplasmic domain which occurs as a result of conformational change in the IFN
receptor chain upon IFN binding, leads to the subsequent phosphorylation of Tyrosine
residues [26, 56, 115]. This is followed by the recruitment of signal transducers and
activators of transcription (STAT1 and 2) which then undergo phosphorylation at specific
tyrosine residues and associate to form a STAT1/STAT2 heterodimer [26, 56]. This
heterodimer then associates with the Interferon regulatory factor 9 (IRF9) forming the
Interferon stimulated gene factor 3 (ISGF3) which is then translocated to the nucleus,
leading to the activation of interferon stimulated genes (ISGs) [56, 115]. Binding of IFN
gamma (Type II interferon) leads to the phosphorylation and activation of the JAK1 and
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JAK2 with the subsequent recruitment and phosphorylation of STAT1 homodimer [109].
This forms the IFN gamma activation factor (GAF) which is translocated to the nucleus
leading to expression of ISGs [115]. The ISGF3 binds to the DNA gene sequence on the
IFN stimulated response elements (ISRE) while GAF binds to the DNA on the gammaactivated sequence (GAS) elements [109, 115]. Ultimately, both processes lead to the
antiviral state through the production of various antiviral proteins. Of the seven known
STAT proteins in mammals, STAT1 and STAT2 are predominantly involved in signaling
through the IFN receptor complex [115]. Therefore, JAK-STAT signaling pathway and
its regulation-the central component of IFN signaling-are responsible for the antiviral
effector functions.
1.2.2 An overview of the innate immune response and its relevance to PRRSV
PRRSV is sensitive to type I Interferon treatment. Primary PAM cells pretreated
with Interferon alpha (IFN-α) inhibits PRRSV replication [18]. Upon entry of virus into
host cells, the recognition of pathogen associated molecular patterns (PAMPs) by pattern
recognition receptors (PRRs) activates innate immune signaling. For instance, the
recognition of double stranded RNA (dsRNA) by Rig-1-like receptors (RLRs) leads to
inflammatory response through NF-ĸβ nuclear transcription factor or through the
activation of interferon response involving the phosphorylation and nuclear translocation
of interferon regulatory factors (IRF3 and IRF7) [115]. The interferon then binds to the
interferon receptor on the cell surface, thereby activating the expression of various IFN
stimulated genes (ISGs). This is dependent on the JAK/STAT signaling pathway [115].
Unlike swine influenza virus infection which leads to upregulation of IFN-α, PRRSV
modulates the IFN response, thereby antagonizing the antiviral response [90, 134].
Suppression of IFN-α response correlates with enhanced PRRSV replication. Stimulation
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of cells with low level of IFN-α has been shown to enhance PRRSV infectivity [29]. One
study showed that although PRRSV induced the transcription of IFN-α, very low amount
of this cytokine could be detected in supernatant, suggesting that PRRSV interferes with
either the post-transcriptional or translational step of IFN-α synthesis [155]. PRRSV
nonstructural proteins nsp1, 2, 4, and 11 have been shown to downregulate the IFN-α
response [24, 90]. The nsp1α and nsp1β proteins interfere with IRF3 phosphorylaton and
nuclear translocation, thereby inhibiting the IFN synthesis [14]. Further, PRRSV nsp1β
blocks the nuclear translocation of the IFN-stimulated gene factor 3 (ISGF3), a
heterotrimer of STAT1, STAT2, and IRF9. This leads to the inhibition of expression of
ISGs important in the antiviral response [102]. MARC-145 cells infected with PRRSV
followed by IFN-α treatment showed significantly low ISG15 and ISG56 expression as
compared to mock infected cells [102].
1.2.2.1 A summary of PRRSV and ISGs
Interferon does not induce antiviral state on its own. Rather, this is dependent on
the activity of various ISGs that are induced upon interferon treatment. Protein kinase R
(PKR) is a well-studied classical ISG that is induced upon interferon treatment. Upon
virus infection, it is activated in cells following recognition of double stranded RNA
(dsRNA) [146]. The antiviral state is induced as a result of stall in cellular translation
following phosphorylation of the eukaryotic translation initiation factor, eIF2α [148].
Studies suggest that PKR exerts antiviral effect via inhibition of PRRSV gene
transcription [108]. Interestingly, PRRSV is also known to interfere with PKR activation
in porcine alveolar macrophages (PAMs) and this may help to evade the antiviral
response during early infection [148]. However, another study has shown that PKR plays
a pro-viral role during PRRSV infection [140].
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The role of many ISGs in PRRSV replication has not been extensively studied.
Although IFITM3 has been shown to inhibit several enveloped viruses, very limited
information on the role of this restriction factor on replication of the members of
arterivirus family is available. One study has reported the antiviral role of the interferon
stimulated gene ISG12A in PRRSV replication in vitro [60]. ISG12A localized in the
mitochondria and interfered with cell cycle regulation [60]. Another important restriction
factor is the interferon stimulated gene ISG20 that inhibits several RNA viruses [34, 143,
160]. ISG20, a 3’-5’ exonuclease specifically acting on ssRNA, was shown to upregulate
the expression of several antiviral gene transcripts, including a subset of ISGs [143].
However, the role of this restriction factor in PRRSV replication has not been
characterized.
1.2.2.2 IFITM3 and PRRSV infection
A recent study has demonstrated the antiviral role of IFITM3 on PRRSV
replication. Overexpression of IFITM3 in MARC-145 cells or porcine alveolar
macrophage (PAMs) showed significant reduction in the PRRSV titer [153]. Further,
knockdown of endogenous IFITM3 enhanced virus replication [153]. IFITM3 did not
inhibit the attachment or entry into the endocytic vesicles [153]. In contrast to a previous
study that showed that PRRSV enters into early endosomes only, this study showed that
PRRSV is first trafficked through early endosome, then to late endosomes and lysosomes
[131, 153, 156]. PRRSV was shown to colocalize with IFITM3 positive endosomes and
lysosomes and IFITM3 restricted PRRSV by preventing membrane fusion [153]. Further,
altered accumulation of cholesterol within the endosomes was shown to be important in
the IFITM3 mediated restriction of PRRSV [153].
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1.2.3 An overview of Interferon stimulated genes (ISGs) and their activation
Pattern recognition receptors (PRRs) are specialized at detecting pathogens
through their recognition of pathogen associated molecular patterns or PAMPs [1, 125].
The PRRs broadly recognize different classes of pathogens. These can be divided into
either the non-cytosolic PRRs or the cytosolic PRRs. The cytosolic PRRs recognize
either singe stranded or double stranded viral RNA or DNA. The cytosolic PRRs such as
the RIG-1 and MDA5 recognize viral nucleic acids, i.e. single stranded RNA (ssRNA) or
double stranded RNA (dsRNA) and the differential recognition of dsRNA is dependent
on the length of the dsRNA. The RIG-1 receptors recognize 5’triphosphate RNA, a nonself RNA signature [1, 125]. On the other hand, the cyclic GMP-AMP synthase (cGAS)
and the AIM2-like receptors (ALRs) detect viral DNAs. In addition, detection of foreign
RNA also activates the endoribonuclease RNaseL that cleaves the foreign RNA with the
production of additional PAMPs that further stimulates the Rig-1 like receptors (RLRs)
[56]. Another important sensor of foreign RNA is the protein kinase R or PKR that also
plays an important role in activating the innate immune response against pathogens [95].
Overall, the detection and activation of the PRRs upon recognition of the viral nucleic
acids activates the downstream signaling through the adaptor proteins- stimulator of IFN
genes (STING) and mitochondrial antiviral signaling protein (MAVS) at the endoplasmic
reticulum (ER) and mitochondrial membrane interface [56, 115, 125]. This occurs as a
result of the interaction of caspase activation and recruitment (CARD) domain on the
RLRs with the mitochondrial adaptor molecules. Activation of STING/MAVS leads to
phosphorylation and activation of the IFN response factors 3 or 7 (IRF3 or IRF7) which
form homodimers [56, 125]. In addition, phosphorylation with ubiquitination and
degradation of IĸB activates the nuclear transcription factor NF-ĸB. The activated
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IRF3/IRF7 and NF-ĸB are translocated to the nucleus where binding to specific
promoters leads to the induction of IFN synthesis as well as activation of a subset of ISGs
[56, 115]. Activation of IRF3, IRF7 and NF-ĸB is necessary to induce the expression of
IFNβ from the IFNβ promoter [56]. In addition, some of the IRFs and PRRs may also be
activated that enhances pathogen detection and antiviral immune response. IFN binds to
the IFN receptor complex on the cell surface thereby activating the signaling through the
JAK-STAT pathway [115]. This eventually leads to the induction of various ISGs with
the subsequent induction of the antiviral response.
1.2.3.1 Negative regulation of IFN signaling by ISGs
Cells enter a state of IFN desensitization in which the IFN response is negatively
regulated [78]. This allows cells to recover from the IFN signaling whereby cells return
to the normal state before IFN sensitization [115]. On the other hand, IFN dysregulation
leads to continued IFN response leading to various autoimmune diseases. The negative
regulation of IFN can occur either through cell intrinsic mechanisms or by the action of
various ISGs [115]. The two important ISGs that negatively regulate the IFN signaling
are the suppressor of cytokine signaling (SOCS) and the ubiquitin specific peptidase 18
(USP18). The SOCS family of proteins acts as kinase inhibitors. They bind to
phosphorylated tyrosine residues which inhibit STAT binding [115]. The SOCS1 and
SOCS3 function as pseudosubstrates for the receptor-associated JAKs. The SOCS
proteins play an important role in early desensitization and depending on the cell type,
their basal level of expression may vary, which determines the level of responsiveness of
cells to IFN treatment [115].
Long-term or sustained desensitization to IFN signaling is maintained by USP18.
The covalent linkage of the IFN induced ubiquitin- like protein (ISG15) to proteins is
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referred to as ISGylation [115]. The peptidase activity of USP18 is necessary for the
removal of the ISG15 congujates, a process known as deISGylation [10]. Consequently,
USP18 knockdown significantly enhances type I IFN responsiveness thereby making the
cells resistant to virus infection as demonstrated in animal model studies [115]. The longterm desensitization of IFN signaling by USP18 is dependent on binding of the USP18 to
the intracellular domains of the IFN alpha receptor 2 (IFNAR2). This leads to
conformational change in the extracellular domain of the IFNAR2 which inhibits the
binding of the low affinity type I IFN, i.e. IFN alpha [10, 115]. However, the binding of
IFN beta, a high affinity type I IFN, is unhindered and therefore, responsiveness to IFN
beta is unaffected despite the binding of USP18 to IFNAR2. Also, since USP18 binds
specifically to the IFNAR2, it is unable to affect the type II IFN signaling [115].
1.2.4 Interferon induced transmembrane protein 3 (IFITM3) family
The members of the interferon induced transmembrane family (IFITM) of
proteins are important restriction factors that are constitutively expressed in many cell
types [6, 115]. Although most cell types are known to express IFITM proteins, their basal
level of expression may vary across cell types. Interferon (IFN) treatment potently
induces IFITM expression in cells [6]. In humans, IFITM1, IFITM2, and IFITM3,
together with IFITM5 form a gene cluster [6]. The IFITM1, 2, and 3 proteins are
commonly known as the antiviral IFITMs as they are known to restrict a number of
enveloped viruses. The IFITM5 is associated with osteoblast and is non-antiviral in
function. In addition, humans also have IFITM10 gene that is located outside of the
IFITM gene cluster and its function is not known yet [6]. IFITM1 is mostly expressed in
the plasma membrane while IFITM2 and IFITM3 are expressed in the early and late
endosomes and are known to inhibit a number of enveloped viruses by preventing their
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release into the cytosol [121]. In cell culture, IFITM knockout mouse embryonic
fibroblasts (MEFs) were shown to be highly susceptible to Influenza A virus (IAV)
infection. Likewise, in vivo studies showed that IFITM knockout mice were highly
susceptible to the pathogenic H1N1 strain (A/PR/8/34) [4, 16, 35].
1.2.4.1 Summary of IFITM domains and membrane topology
IFITM proteins consist of five domains: the N-terminal domain (NTD),
intramembrane domain (IMD), conserved intracellular loop (CIL), transmembrane
domain (TMD), and C-terminal domain (CTD) [6, 121]. The current model of IFITM
membrane topology classifies it as a type II transmembrane protein. The NTD
(intracellular) faces cytosol while the CTD (extracellular), together with the CIL, faces
the lumen of the endoplasmic reticulum/endosome [6, 121]. Both IFITM2 and IFITM3
contain YXXF motifs [62]. The Tyr20 (Y20) in the NTD is highly conserved in IFITM2
and IFITM3 and is important for the internalization into endosomes [6, 61, 104]. There
are four lysines in the IFITM that can be ubiquitinated, one of which is located in the
NTD (K24) [151]. The Lys24 in the NTD is most efficiently ubiquitinated by Lys48
ubiquitin linkage as compared to the other lysines (located at the conserved intracellular
loop). Ubiquitination at K24 position promotes degradation and has been shown to affect
the antiviral activity of IFITM [6, 151]. Ubiquitination therefore regulates IFITM
expression and protein turnover. While two highly conserved cysteine residues are
located in the IMD, a poorly conserved cysteine residue is located at the junction between
the CIL and the TMD [6, 121]. Substitution of cysteine with alanine has been shown to
inhibit antiviral activity [6, 64]. These cysteines are palmitoylated, containing covalently
linked palmitic acid and have been shown to be important in the subcellular localization
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of IFITM [6, 150, 151]. The palmitoylation of Cys72 residue plays an especially
important role in the IFITM mediated virus restriction [6, 150, 151].
Broadly, based on the membrane topology of the IFITM proteins, several key
features in the context of antiviral functions can be highlighted. As a type II
transmembrane protein, the amphipathic helix of the hydrophobic domain 1 and the
transmembrane helix of the hydrophobic domain 2 are critical for the antiviral activity of
IFITM [5, 119]. Multimerization of IFITM is considered essential for antiviral activity.
The IFITM proteins have been shown to induce positive (+) curvature as visualized from
the cytosolic side [51, 119]. Also, studies have indicated that interaction of IFITM with
other proteins, chiefly the zinc metalloprotease, ZMPSTE24, may be important for its
antiviral function [84, 119]. In addition, IFITM proteins also modulate the activity of the
vacuolar ATPase (v-ATPase) [119, 141]. This is important because it provides yet
another indirect mechanism for virus inhibition by trapping them within the acidic
endolysosomal compartments and targeting them for degradation. In addition, some
studies have shown that IFITM may increase cholesterol incorporation within the
endosomal membrane [3]. These studies suggest that not only IFITM inhibits viruses by
direct mechanism, but also various indirect mechanism of inhibition may be involved.
The most widely accepted model is the tough membrane model in which IFITM directly
alters the physical properties of the membrane. Recent studies with IAV using live cell
imaging have shown that IFITM3 inhibits fusion of viruses by partitioning into virus
positive endosomes [124]. When A549 cells were transduced with GFP-fused IFITM3,
the IFITM3 expressing cells were protected from IAV infection [124]. IFITM3 associated
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with domains where cell-virus fusion occurs, thereby imposing a block in the virus entry
step [51].
1.3 IFITM3 mediated antiviral activity
Several cell-cell fusion studies have provided key insights as to how IFITMs
perform their antiviral functions [83]. These studies are based on the cell membrane
expression of IFITM and viral envelop proteins, whereby the ability of IFITM to inhibit
fusion of the envelop proteins is studied. A recent cell-cell fusion assay using human
metapneumovirus (hMPV) fusion (F) protein-based luciferase activity demonstrated that
IFITM3 protein significantly inhibits membrane fusion mediated by hMPV [91]. These
assays suggest that IFITM3 may alter the physical properties of the membrane, thereby
rendering the cell-virus fusion process unfavorable.
1.3.1 Virus-host membrane fusion step: the main target for IFITM3
Fusion is a critical step in virus entry. For example, following attachment to the
cell surface receptor and internalization, the influenza A virus (IAV) undergoes
trafficking through the endocytic pathway. Within the late endosomes, the low pH
environment triggers a conformational change in the IAV hemagglutinin (HA) protein, a
major viral envelope protein, thereby allowing the fusion of viral membrane with the
endosomal membrane [39]. Precisely, this occurs through the fusion of the outer leaflet of
the viral membrane with the leaflet of the endosomal membrane on the luminal side. The
outcome of this process is the formation of a hemifusion intermediate. This is followed
by the fusion of the inner leaflet of the viral membrane with cytoplasmic leaflet of the
endosomal membrane, forming a stable fusion pore [104, 120]. This enables the release
of the viral ribonucleoprotein (vRNP) into the cytosol. The IFITM3 protein imposes a
block in the IAV fusion step and as a result, the cytosolic entry of the vRNP and its
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eventual transport into the nucleus is inhibited [39, 104]. IFITM3 has been shown to
partially co-localize with the late endosomal and lysosomal markers- Rab7 and LAMP-1
respectively, thus placing it in the optimum position for inhibiting IAV, which mainly
enters through late endosomes [39]. Similarly, in a recent study of classical swine fever
virus infection, IFITM proteins have been shown to colocalize with Rab5, Rab7, and
LAMP-1 endosomal markers [82].
1.3.2 The tough membrane model
According to the tough membrane model, IFITM may increase the rigidity of the
membrane thereby preventing the process of cell-virus fusion and this can occur in a
number of ways. Viruses such as HIV-1 and HCV require interaction with one or more
co-receptors following the attachment of specific virus protein to the receptors. First,
upon initial binding to the receptor, the pair moves laterally until it encounters the coreceptors. This triggers the fusion peptide insertion [104]. IFITMs decrease membrane
fluidity, thereby preventing the lateral movement of the receptor complex. The
intramembrane domain 1 (IM1) of IFITM that integrates into the outer (cytoplasmic)
leaflet of the endosomal membrane has been shown to be important in this process [104].
Other viruses such as IAV require the clustering of the HA receptors. The two HAs with
their fusion peptides inserted into the host membrane, move through the membrane until
they coalesce. This allows the formation of fusion pore. IFITM proteins restrict this
movement and inhibit fusion pore formation [59, 104]. Not only does the interaction of
the IM1 domain of IFITM decreases membrane fluidity, but also induces a curvature that
makes fusion pore formation energetically unfavorable [51, 104]. Several studies support
the tough membrane model for IFITM3 mediated virus restriction. Studies using
fluorescence lifetime imaging microscopy (FLIM) have shown that IFITM3
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overexpression leads to decrease in host cell membrane fluidity with the restriction in
lateral movement of plasma membrane proteins [83, 86]. In addition, the IFITM proteins
have been proposed to concentrate in the receptor enriched regions in the cell membrane
called lipid rafts where virus binds to receptors [3, 15, 104]. Therefore, even a relatively
low level of expression of IFITM may inhibit viruses by altering the cell membrane
[104]. Overall, IFITMs restrict virus entry by making the membrane less fluid and
increases stiffness in the cytoplasmic leaflet of the endosomal membrane [51].
In addition to the direct mechanism, IFITMs may also indirectly inhibit viruses by
modulating the endosomal acidification. Studies on IAV support this model in which it
was shown that IFITM overexpression leads to expansion of acidified organelles [39]. In
another study, it was shown that the IAV variants that fuse at a higher pH were more
resistant to the IFITM mediated restriction. This allows the viruses to escape the more
acidic, late endosomal compartments where IFITM3 are predominantly expressed [45].
In addition, co-immunoprecipitation studies have shown direct association between the
IFITM3 proteins and the vATPase [141]. The IFITM3 proteins have also been implicated
in interfering with the lipid homeostasis; IFITMs have been shown to increase the
accumulation of cholesterol in the late endosome, thereby imposing a block in virus
fusion. The IFITMs bind to the vesicle associated membrane protein-A (VAPA) and
competes with the oxysterol binding protein (OSBP)-a regulator of IFITM trafficking-for
VAPA binding which increases cholesterol content in the endosomes [3, 147].
Amphotericin B is an antifungal drug that increases membrane fluidity by
forming ion leak channels [6]. Amphotericin B has been shown to restore membrane
fluidity thereby reversing the effect of IFITM3 on virus restriction [86, 91]. The
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Amphotericin B drug may disrupt a higher order complex of IFITMs [6]. This could be a
possible explanation for its effect on membrane fluidity. Amphotericin B treatment has
been shown to fully restore infection of hMPV, IAV, etc. in cells overexpressing IFITM3
[86, 91].
1.3.3 Diverse roles of ISGs
1.3.3.1 Effects of host restriction factors on virus infection
Upon binding of enveloped virus to cell surface receptor, it either enters into the
cell by fusion with cell membrane or becomes internalized in the vesicles for trafficking
within the endosomes, a process known as receptor mediated endocytosis. Within the
acidic endosomes, virus fusion is mediated thereby allowing virus uncoating and release
of the genome. In general, this occurs as a result of low pH triggered conformational
change in the viral envelope proteins and insertion of the fusion peptide into the cell
membrane [54]. Replication and transcription of the virus is followed by packaging of the
genome, then assembly and release. Each of these steps within the virus life cycle can be
a potential target for the host’s restriction factors. In recent years, a wide variety of
restriction factors have been identified [23, 117, 119]. Restriction factors inhibit virus at
various stages of virus infection. Restriction factors such as the Cholesterol-25Hydroxylate (CH25H) and IFITM1 are known to inhibit fusion of enveloped virus with
the host membrane, thereby blocking virus entry [115]. IFITM3 blocks host-virus
membrane fusion within endosomes and inhibits virus uncoating. The trapped virus is
then degraded within the highly acidic endolysosomal compartments [104]. In addition,
incorporation of IFITM into the newly released virion membranes inhibits the subsequent
fusion of virus and infection of new host cells [23]. Myxovirus resistance (Mx) proteins
prevent transport of viral DNA or vRNPs into nucleus. The human ortholog MxA protein
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blocks the release of influenza vRNP in the cytoplasm. ZAP prevents translation of viral
RNA by targeting them for degradation. Viperin inhibits virus budding from the host cell
while Tetherin prevents the release of virus from the cell [23]. However, viruses have
also evolved with countermeasures to evade the host restriction factor that allows
successful infection of host cells [72]. Some viruses have co-opted the host restriction
factors by hijacking them for their own benefit [157].
Table 1.1 Summary of important cellular restriction factors and their antiviral roles [23].
Restriction factor

Stage of virus life cycle

CH25H

entry

IFITM1,2,3

entry, fusion

Mx

Nuclear import, transcription

ZAP

translation

TRIM25

replication

Tetherin

egress

Viperin

transcription

ZMPSTE24

entry

1.3.3.2 Summary of ISG profiles and their diverse functions
Stimulation of the ISGs is a major step in the antiviral response. Signaling
through the JAK-STAT pathway eventually leads to the activation of various ISGs. The
ISGs can be grouped into various categories depending on their antiviral roles or their
activity as regulators of the interferon signaling pathway. Broadly, there are three types
of ISGs: antiviral effectors, positive regulators and negative regulators [117]. One of the
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most widely studied IFN stimulated genes is the MX family of proteins [136]. There are
several ISGs that are important for antiviral effector functions and include IFITM3,
CH25H, TRIM, Viperin, Tetherin, etc. [23]. Some of the classical IFN induced antiviral
ISGs include MX1, OAS and PKR [116]. Broadly, these ISGs inhibit viruses at various
stages of replication cycle. On the other hand, there are also ISG types that function as
negative regulators of IFN signaling [116]. SOCS and USP18 both interfere with the
JAK-STAT pathway thereby inhibiting IFN signaling. There are several positive
regulators of IFN signaling and includes various PRRs, cGAS, RNAseL, PKR, IRF3, 7,
and 9 [115]. IRF1 is an important positive regulator which upon expression can directly
stimulate the production of various ISGs. It is important to note that IRF1 is able to
induce expression of hundreds of ISGs in the absence of IFN and STAT1 signaling [115].
Therefore, IFN regulatory factors function as important component that regulate the IFN
signaling pathway and the production of ISGs. Upon sensing of virus nucleic acids by
cytosolic PRRs, the activated IRFs then induce IFN gene expression. The IFN signals
through the JAK-STAT pathway to induce the antiviral state. While many ISGs inhibit
viruses, some ISGs have been shown to enhance virus replication. Characterization of
ISG profile against six highly pathogenic viruses showed that a cluster of ISGs enhanced
virus replication [116, 117]. Some viruses have co-opted the ISGs for their own benefit.
For example, HCoV-OC43 virus replication is enhanced by upregulation of IFITM3
although IFITM3 is known to potently inhibit several enveloped viruses [157]. Viperin is
an important antiviral effector against many viruses [115]. However, HCMV viruses
encode for proteins that co-opts viperin and disrupts actin cytoskeleton by modulating
ATP production [116]. This enhances HCMV infection, indicating that HCMV hijacks
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ISG for successful infection. Therefore, for such viruses, upregulation of specific ISG
does not correlate with antiviral activity. While some ISGs promote IFN signaling either
by directly acting on the JAK-STAT pathway or on the IFN regulatory factors, there are
other ISGs which act as negative regulators and target the PRRs, IRFs or the components
of the JAK-STAT pathway [85, 116].
Studies have demonstrated redundancies in the ISG antiviral activity as mice
defective in classical antiviral pathways such as Mx1 and PKR are still able to generate
antiviral response [159]. In HCV infected patients, upregulation of a unique set of 36
signature ISGs in the liver upon IFN treatment has been show to correlate with reduction
in HCV viral load [17]. Screening of ISGs for antiviral activity against Dengue virus
(DNV) and West Nile virus showed viperin, ISG20, PKR and IFITM2/3 as the major
antiviral effectors [63]. In a study that characterized ISG profile by testing for 380 genes
for antiviral activity against six pathogenic viruses, a group of ISGs showed broad
antiviral activity while others showed more restricted specificity [117]. Specifically,
IRF1, IFITM3, Rig-1, MDA5 were identified as broad acting antiviral effectors [116,
117]. When antiviral activity was analyzed for each virus, a unique ISG profile was
observed for each virus with some overlap in the profile across different viruses. More
importantly, studies have shown that antiviral activity for most ISGs studied falls in a
spectrum in which a group of ISGs show low to moderate antiviral activity while others
show very high antiviral activity [117]. Also, it has been shown that the antiviral activity
is greater when pairs of ISGs were expressed as compared to either one alone, indicating
that ISGs work together to reinforce the IFN induced antiviral activity [116].

27

1.3.3.3 Antagonism of the antiviral response and IFN signaling by viruses
Viruses have evolved countermeasures to subvert the antiviral defense mechanism
of the host. Viruses encode for proteins that can impede antiviral response either at the
level of interferon synthesis or at the JAK-STAT signaling [56, 69, 81]. One of the
important groups of virus in this regard is the paramyxoviruses, a family of negative
sense RNA viruses. Some of the viruses belonging to the paramyxovirus family typically
undergo G-nucleotide insertion editing that leads to frameshift in transcription. The
proteins that are important in the IFN antagonism are P protein and the V protein that are
generated as a result of the frameshift [56]. These proteins inhibit IFN by targeting its
components which include PRRs (Rig-1, MDA5), IRF3, and STAT1/2 [22, 56]. The NS1
protein of Influenza A virus, an orthomyxovirus, is known to target the Rig-1 receptors as
these PRRs play an important role in the detection of Influenza virus RNA. The NS1
protein inhibits Rig-1 mediated antiviral signaling by blocking the ubiquitination of RIG1 that is dependent on the activity of TRIM25 [44, 56]. The IFN regulatory factor, chiefly
IRF3 is another target for the viral proteins [22]. Paramyxovirus V protein inhibits IRF3
by polyubiquitination and degradation of IKKε/TBK1, thereby preventing IRF3
phosphorylation and translocation into the nucleus [56]. Likewise, HPV-16 E6 proteins
directly inhibit IRF3. On the other hand BGLF4 protein of Epstein-Barr virus (EBV) is
known to decrease the active, phosphorylated IRF3 thereby reducing the IFN response
[56, 139].
The type I and type III IFN JAK-STAT signaling converges at the level of
STAT1/STAT2 heterodimer formation. The EBOV VP24 protein inhibits the nuclear
translocation of the phosphorylated STAT1/STAT2 [154]. On the other hand, the V
proteins of paramyxoviruses target the STAT1 and STAT2 for proteasomal degradation
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that is dependent on the polyubiquitination of the STAT proteins [56]. The nuclear
translocation of ISGF3 is inhibited by HPV-16 E7 proteins [7]. In addition, some
paramyxoviruses inhibit IFN signaling by sequestering STAT1 and STAT2 within the
cytoplasm [56]. The Sendai virus C protein inhibits phosphorylation of tyrosine and
serine residues on the STAT1/STAT2 [56]. Therefore, degradation, dysregulation in
phosphorylation, and sequestration of the STAT1/SAT2 are common strategies used by
viruses to antagonize the IFN induced antiviral response.
1.4 A brief overview of Zinc metalloprotease-ZMPSTE24
ZMPSTE24 is a transmembrane zinc-metalloprotease whose catalytic activity is
dependent on the highly conserved HEXXH motif [65, 106, 107]. ZMPSTE24 has
promiscuous substrate specificity; it cleaves both prenylated and non-prenylated
substrates [55]. It cleaves the three amino acids within the C-terminal CAAX motif,
releasing the –AAX from the CAAX motif [9]. The ZMPSTE24 is an ortholog of the
Ste24p in yeast, sharing high degree of sequence identity with Ste24p [8]. In yeast, the
Ste24 is required for the maturation of the mating pheromone a-factor [94]. In mammals,
ZMPSTE24 is critical for the processing of the prelamin A precursor to lamin A, a
critical component of the nuclear lamina [9, 55, 122]. ZMPSTE24 is constitutively
expressed and is localized in the inner nuclear membrane. Lamins are intermediate
filament proteins that regulate the structure and shape of the nuclear envelope [49]. The
processing of the precursor premlamin A to lamin A includes three steps: farnesylation of
cysteine, removal of –AAX, and methylation of the farnesylcysteine. The mature lamin A
is formed following removal of fifteen amino acids from the C-terminus [9, 122].
Mice defective in the ZMPSTE24 gene show accelerated ageing, resembling the
Hutchinson-Gilford Progeria Syndrome (HGPS), or disease resulting from LMNA gene
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(which encodes for prelamin A) mutation [20, 40]. In ZMPSTE24-/- mice, there is
increased accumulation of the prelamin A, deficiency in mature lamin A, and defectively
shaped nuclear envelope [40]. ZMPSTE24 deficient mice show bone fracture and muscle
weakness [13].
1.4.1 ZMPSTE24 as a host restriction factor
Recently, ZMPSTE24 has been shown to restrict a number of enveloped viruses
that depend on low pH for fusion [43]. ZMPSTE24 inhibits a diverse array of enveloped
RNA viruses including IAV, Zika, Ebola, etc., as well as DNA viruses, chiefly cowpox
and vaccinia virus [43]. However, murine leukemia virus (an RNA virus) and adenovirus
(a DNA virus) were shown to be resistant to ZMPSTE24 [43]. In a recent study,
ZMPSTE24 was shown to work in cooperation with IFITM3 to inhibit entry of
arenaviruses [123]. In general, ZMPSTE24 restricts fusogenic viruses that depend on the
low pH environment of the endosomes for fusion [43]. Since adenovirus is lysogenic, it is
plausible that this group of viruses is resistant to ZMPSTE24 [43]. Like IFITM3,
ZMPSTE24 is constitutively expressed. However, unlike IFITM3, ZMPSTE24 protein is
not upregulated by interferon treatment [43]. ZMPSTE24 was identified as one of the
binding partners of IFITM3 and its association with IFITM3 is enhanced by interferon
treatment [43]. Mice with defective ZMPSTE24 gene were highly susceptible to IAV
infection. However, interferon treatment, which upregulates IFITM3 expression thereby
recruiting more ZMPSTE24, restores the antiviral activity of IFITM3 [43, 84].
ZMPSTE24 has been proposed to function as a downstream effector of IFITM3 [84,
123]. Studies suggest that ZMPSTE24 exerts its antiviral activity via its interaction with
IFITM3, chiefly during entry of virus into the endosomes. In cells overexpressing
ZMPSTE24, this restriction factor was shown to block IAV entry by trapping viruses
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within the highly acidic endosomes [43]. Therefore, ZMPSTE24 restricts IAV by
preventing cytosolic release. PRRSV is an enveloped RNA virus that depends on
endosomal trafficking for cytosolic entry. Given the ability of ZMPSTE24 to restrict a
wide variety of enveloped RNA viruses, studying the role of this restriction factor on
PRRSV replication may reveal more on PRRSV and its interaction with host restriction
factors.
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2.1 Abstract
Interferon induced transmembrane protein 3 (IFITM3) is a member of the family of
interferon stimulated genes (ISGs) that inhibits a diverse array of enveloped viruses
which enter into host cell by endocytosis. Porcine reproductive and respiratory syndrome
virus (PRRSV) is an enveloped RNA virus causing significant economic losses to the
swine industry. Very little is known as to how IFITM3 restricts PRRSV. In this study, the
role of IFITM3 in PRRSV infection was studied in vitro using MARC-145 cells. IFITM3
overexpression reduced PRRSV replication, while siRNA induced knockdown of
endogenous IFITM3 increased PRRSV RNA copies. Colocalization of virus with
IFITM3 was observed at both 3 and 24 hours post infection (hpi). Amphotericin B only
partially restored PRRSV replication in MARC-145 cells. Accordingly, very little colocalization between PRRSV and the late endosome and lysosome marker (LAMP-1) was
observed. Quantitative analysis of confocal microscopic images showed that an average
of 73% of IFITM3 expressing cells were stained positive for PRRSV at 3 hpi, while only
an average of 27% of IFITM3 expressing cells were stained positive for PRRSV at 24
hpi. These findings suggest that IFITM3 may restrict PRRSV at the post-entry steps.
Future studies are needed to better understand the mechanisms by which this restriction
factor inhibits PRRSV.

Key words: virus restriction factors, interferon stimulated genes (ISGs), Interferon
induced transmembrane protein 3 (IFITM3), porcine reproductive and respiratory
syndrome virus (PRRSV)
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2.2 Introduction
Restriction factors function to antagonize virus infection and can target viruses at
various stages of their life cycle. They block cytosolic entry of enveloped viruses by
either directly inhibiting virus fusion at the cell surface or by preventing fusion within the
endosomes [115]. The Interferon induced transmembrane protein 3 (IFITM3) belongs to
a class of interferon stimulated genes (ISGs) that inhibits viral-host membrane fusion
within the endosomes [104]. Some of the well-studied classical ISGs include MX1, OAS,
and PKR that play important role during virus infection [52, 99, 116]. IFITM proteins are
constitutively expressed in various cell types and are potently induced upon interferon
treatment [39, 42]. Of the five known members of the IFITM family, IFITM1, 2, and 3
are antiviral restriction factors and inhibit viruses that either enter by direct fusion with
the cell membrane (IFITM1), or by endosomal trafficking (IFITM2 and IFITM3) [6, 16].
The role of IFITM3 in Influenza A virus (IAV) infection has been very well
studied [4]. IFITM3 knockout mouse embryonic fibroblasts (MEFs) are highly
susceptible to IAV infection [16]. The cytosolic release of the IAV viral
ribonucleoproteins (vRNPs) is restricted by IFITM3, thereby blocking their subsequent
nuclear entry [39, 104]. Enveloped viruses such as IAV that are pH sensitive and require
low pH for fusion are highly restricted by IFITM3 [121]. The IFITM3 protein is
expressed in the early or late endosomes and strongly inhibits viruses that enter through
late endosomes. Overall, the block to virus uncoating results in the trapping of viruses in
the acidic endolysosomes within which it undergoes degradation [39]. IFITM3
expression has been shown to expand acidified endosomes as evident from colocalization
with endosomal markers, chiefly Rab7 and LAMP-1 [39]. Other viruses such as West
Nile virus, vesicular stomatitis virus, etc. that fuse at pH greater than 6 are also inhibited
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by IFITM3 [47, 142]. IFITM3 proteins inhibit a broad spectrum of enveloped RNA
viruses [16, 47]. Recently, IFITM3 has also been shown to restrict Zika virus, an
important emerging pathogen [112].
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped,
positive sense, and single stranded RNA virus. It is a highly pathogenic virus that mainly
causes respiratory disease in newborn pigs and reproductive disease in sows [32].
PRRSV belongs to the order Nidovirales within the family Arteriviridae [32]. Upon
initial binding and internalization via binding to the sialoadhesin molecules, PRRSV
enters into early endosome through a clathrin-dependent pathway in clathrin coated
vesicles and is dependent on its binding to the CD163 receptor [96, 156]. CD163
functions as the principal PRRSV receptor that recycles between plasma membrane and
endosomes [19, 144, 156]. PRRSV is known to enter into the endocytic pathway for
cytosolic entry [73, 96]. However, one study showed that PRRSV does not appear to be
associated with later endosome/lysosomes [131].
The impact of many ISGs including IFITM3 on PRRSV replication has not been
extensively studied. One recent study has reported the antiviral role of IFITM3 on
PRRSV infection [153]. Zhang et al. showed that IFITM3 did not block PRRSV entry
into endosome or lysosome, but restricted PRRSV fusion through cholesterol
accumulation within endosomal membrane [153]. These authors have further suggested
that IFITM3 is incorporated into PRRSV virions, which results in reduced infectivity and
cell-cell spread of PRRSV [38]. In this study, we have examined the role of IFITM3 in
PRRSV replication in MARC-145 cells. Our data suggests that IFITM3 does not impact
virus entry, but restricts PRRSV replication at post-entry steps.
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2.3 Materials and methods
2.3.1 IFITM3 transfection in MARC-145 cells
MARC-145 cells were seeded at 2x105 cells per well in a 12-well plate in DMEM
medium supplemented with 10% FBS and 1% Penicillin-Streptomycin (complete DMEM
medium). The 12-well plate was incubated in a humidified chamber at 37 o C with 5%
CO 2 . After 24 h, cells were washed two times in DMEM medium and transfected with
1.25 g of either the pQCXIP vector control (Q-series retroviral vector; Retro-X Q
Vector Set) (Clontech, Cat. No. 631516; Takara Bio Inc.) or pQCXIP expressing the
IFITM3-HA [16, 43] in triplicate wells using lipofectamine 3000 Transfection kit
(Invitrogen), following the manufacturer’s protocol. The retroviral vector pQCXIP
carries puromycin resistant gene and expresses IFITM3-HA, transfected in HEK293
packaging cells for stable expression [43]. Transfection mix prepared as a 1:1 mixture of
DNA and lipofectamine diluted in DMEM medium was added to each well. Briefly, each
of the plasmid DNA was diluted in DMEM medium with P 3000 and mixed with
Lipofectamine 3000 reagent diluted in DMEM. The transfection mix was then incubated
at room temperature (RT) for 20 min after which 200 µl of the DNA-lipid complex was
added dropwise to the respective wells in DMEM medium. After incubation for 6 h at
37o C, the medium was replaced with complete DMEM growth medium. After 72 h, each
of the six wells was infected with PRRSV 23983 at an MOI of 1 for 24 h at 37 o C. Then,
cells together with supernatant were harvested by scraping, and centrifuged at 13,000 rpm
for 3 min. The supernatant and the pellets were stored separately in 1.5 ml
microcentrifuge tubes at -80o C until used for further analysis.
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For colocalization or cytotoxicity experiment, MARC-145 cells at 1x104 cells per
well were seeded in two 8-chamber slides (colocalization study) or a 96-well plate
(cytotoxicity study) in complete DMEM medium and incubated at 37 o C for 24 h. Cells in
8-chamber slides and 96-well plate were transfected with 0.3 µg of either pQCXIP vector
control or IFITM3-HA using lipofectamine 3000 reagent.
For transfection in a 48-well plate, MARC-145 cells were cultured at a seeding
density of 5x104 cells per well. The experiment was performed in two groups. In first
group, cells were transfected with 0.3 µg of either pQCXIP plasmid vector or pQCXIP
IFITM3-HA in triplicates using lipofectamine 300 reagent as described previously. In the
second group, same transfection scheme was followed and then marked as Amphotericin
B treatment group.
2.3.2 siRNA induced knockdown of IFITM3 in MARC-145 cells
MARC-145 cells at a seeding density of 2x105 cells per well were cultured in a
12-well plate. Following 24 h incubation at 37o C, cells were transfected with either
negative control siRNA (Ambion, cat. no. AM4642) or IFITM3 siRNA (Life
technologies, siRNA ID#s195035) at a final concentration of 30 nM per well using
Lipofectamine RNAi max reagent (Invitrogen) according to the manufacturer’s protocol.
Transfection with either negative control siRNA or IFITM3 siRNA was performed in
triplicate wells. Briefly, the siRNA was mixed with RNAi max reagent diluted in DMEM
medium in 1:1 ratio. The mixture was incubated at RT for 5 min after which 125 µl of the
siRNA complex was added dropwise to the respective wells of MARC-145 cells in
DMEM medium. These wells were pre-washed two times with DMEM medium.
Following washing, the 12-well plate was then incubated at 37o C for 6 h. Then the
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DMEM medium was replaced with complete DMEM growth medium and incubated for
72 h. Next, the cells in each well of the 12-well plate were infected with PRRSV 23983 at
an MOI of 1 for 24 h after which cells were scraped and harvested with supernatant.
Following centrifugation at 13000 rpm, supernatant and cell pellets were separated out
and stored at -80o C in 1.5 ml microcentrifuge tubes.
For cytotoxicity experiment, 1.2 µl of either negative control siRNA or IFITM3
siRNA at a concentration of 30 nM was used for transfection in triplicate wells of a 96well plate. Thus 25 µl of transfection mix was added dropwise to the respective wells
with DMEM medium and incubated at 37o C for 6 h after which media was replaced with
complete DMEM growth medium and incubated at 37 o C for 72 h.
2.3.3 Western blot analysis
Cell pellets were resuspended with 60 µl cell lysis buffer (0.01M Tris-HCl pH 8,
0.14 M NaCl, 0.025% NaN 3 , 1% Triton x-100) treated with HaltT M protease and
phosphatase inhibitor cocktail (Thermo Scientific, catalog# 78441) at 1:100 dilution.
Each lysate sample thus obtained from overexpression of either the pQCXIP vector or the
IFITM3-HA was vortexed for 15 s. The tubes were then incubated for 1 h at 4o C, with
vortexing every 15 min. Each tube was then spun at 13,000 rpm for 1 min after which the
lysate was transferred to a new tube. Next, 40 µl of each sample was mixed with 40 µl
(equal volume) of 2x western blot loading buffer treated with beta-mercaptoethanol at
1:50 dilution and 40 µl was loaded in each well. Two gels were loaded with the lysate
samples from each tube. Before loading, each sample in 1.5 ml microcentrifuge tubes was
incubated at 95o C for 5 min and then vortexed for 15 s. Each gel was run at 150 V for 1.5
h and then transferred to nitrocellulose membrane run at 100 V for 1 h. Each
nitrocellulose membrane was blocked by incubating with 10 ml of blocking buffer (5%
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milk powder in 1x PBST) at room temperature (RT) for 1 h with shaking. Then the
membranes were washed with 1x PBST three times for 5 min each with shaking at RT.
Next, the membrane was incubated by shaking overnight at 4 o C with 10 ml of respective
primary antibodies prepared in 5% milk blocking buffer. The following primary
antibodies were used: anti-HA mouse monoclonal 1o Ab against HA tagged IFITM3
(6E2) (Cell Signaling Technology, cat. no. 2367) at 1:1000 dilution, anti-PRRSV SR-30
1o monoclonal Ab (provided by Dr. Eric Nelson) at 1:300 dilution, and mouse
monoclonal anti-beta actin-Ab (Sigma-Aldrich, catalog# A2228) at 1:5000 dilution. Next
day, the membrane was washed with 1x PBST three times for 5 min each with shaking at
RT. The membrane was then incubated while shaking at RT in dark with Goat antiMouse IRDye® conjugated 2o Ab (LI-COR, catalog# 926-32210) diluted to 1:5000 in 1x
PBST. The membrane was washed in 1x PBST and observed using LI-COR Odyssey
Infrared Imaging System. Quantification of the protein (band) intensity was performed
using Image J [113]. Beta-actin house keeping gene was used to calculate relative fold
change in PRRSV N protein expression in IFITM3 overexpressing cells as compared to
vector control cells.
2.3.4 Interferon stimulation of IFITM3 gene in MARC-145 cells
To study the dose dependent response of IFN-alpha treatment on IFITM3 gene
expression, a 12-well plate was seeded with 1x105 MARC-145 cells per well and
incubated for 24 h at 37o C. After 24 h incubation, in duplicate wells, MARC-145 cells
were treated with IFN-alpha at a concentration of either 50 U/ml, or 100 U/ml, or 500
U/ml. The respective IFN-alpha concentrations were prepared by diluting the stock at a
concentration of 8x105 U/ml (stock pre-diluted in 0.1 % BSA and 1x PBS and stored in
aliquots of 10 µl at -80o C) to the respective IFN-alpha working concentrations in DMEM
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complete medium. Two wells were marked as control wells (IFN-alpha untreated) and
were incubated with 1 ml of DMEM complete medium only. After 12 h incubation, the
medium was removed and each well was infected with 1 MOI of PRRSV 23983 for 24 h
at 37o C. Following incubation, the cells from each well were harvested by scraping and
then centrifuged in 1.5 ml microcentrifuge tubes. The cell pellets were stored at -80o C for
analysis of IFITM3 gene expression and PRRSV N RNA copies by RT-PCR.
2.3.5 Immunofluorescence assay and flow cytometry
After 72 h transfection, Amphotericin B at a concentration of 2.5 µg/ml was
added to each of the six wells of a 48-well plate transfected with either vector control
plasmid pQCXIP or IFITM3-HA in triplicates. Another set of six wells that were
transfected similarly in the same plate were not treated with Amphotericin B. After
incubating the plate at 37o C for 1 h, the medium with Amphotericin B drug was removed.
PRRSV 23983 was added at an MOI of 1 to all wells and the plate was incubated at 37 o C
for 24 h. Cells were then fixed with 80% acetone for 20 min at RT, followed by air
drying. Next, FITC conjugated anti-PRRSV Ab specific to N protein (SDOW-17)
(provided by Dr. Eric Nelson) [98] at 1:80 dilution was added to each well and incubated
at 37o C for 1 h. Cells in each well were washed in 1x PBS and then observed under
immunofluorescence microscope for fluorescence staining specific to PRRSV. After
observing, cells in each well were scraped using a cell scraper in 500 µl PBS, then
analyzed by flow cytometry, and mean fluorescence intensity for FITC staining was
calculated. The images were captured at 10x magnification using an Olympus IX70
Inverted-Microscope (Epi-fluorescence and phase contrast).
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2.3.6 Colocalization study using confocal microscopy
For the study of colocalization of PRRSV with endosomal markers, MARC-145
cells were seeded at 1x104 cells per well in three 8-chamber slides for each time point
study. After culturing for 24 h, the cells were infected with PRRSV at an MOI of 10.
Then at three time points-1 h, 3 h, or 6 h after infection, the cells in respective slides were
fixed with 3.8% formaldehyde for 10 min at RT, then washed in 1x PBS for 5 min and
treated with 0.2% Triton x-100 for 10 min, after which cells were again washed once and
incubated with 5% goat serum in PBS (blocking buffer) for 1 h. Then cells were stained
with SDOW-17 (FITC conjugated anti-PRRSV N) monoclonal Ab at 1:80 dilution,
together with either anti-EEA1 Ab (Santa Cruz Biotechnology, sc-365652) or antiLAMP-1 Ab (Santa Cruz Biotechnology, sc-19992) conjugated to Alexa Fluor 647.
Following incubation, the cells were washed three times with 1x PBS, then mounted
using ProLong Gold antifade mounting reagent (Invitrogen). Then the slides were
observed by confocal microscopy. For the quantification of colocalization, Image J was
used [113, 114]. Briefly, for each time point, five random cells were selected and then
with manual thresholding, the threshold range was selected to define the object of interest
distinct from the background (Image J) [114]. The color (yellow) threshold was adjusted
to measure the area of colocalized region (A1). Next, the threshold color was adjusted to
select all five cells to obtain area of the total five cells (A2). The percentage
colocalization was calculated by multiplying the fraction, (A1/A2) by 100. Mean percent
colocalization was calculated for each time point from three selected areas (each with
five cells).
MARC-145 cells cultured in two 8-chamber slides were transfected with either
vector control pQCXIP or IFITM3-HA in duplicate wells of each slide as described
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earlier. For 3 hours post infection (3 hpi) study, PRRSV 23983 at an MOI of 4 was added
to all wells except one vector control transfected well. For 24 hpi study, cells were
infected with PRRSV at an MOI of 1. After infecting cells with PRRSV for the respective
times, the two slides were fixed in 3.8% formaldehyde for 10 min at RT followed by one
wash in 1x PBS for 5 min. The cells in each well were then treated with 0.2% Triton x100 diluted in 1x PBS for permeabilization and incubated at RT for 10 min. Next, the
cells were washed and incubated at RT for 30 min with 5% goat serum in PBS for
blocking non-specific antibody binding. After washing in 1x PBS, cells in each well were
incubated overnight at RT with primary antibody diluted in 5% goat serum. Mouse
monoclonal anti-HA primary antibody against HA tagged IFITM3 (6E2) (Cell Signaling
Technology, cat. no. 2367) was added at a dilution of 1:1600 to all wells except the
uninfected vector control transfected well to which 5% goat serum was added. Next day,
the slides were washed three times with 1x PBS for 5 min each and then incubated for 1 h
at 37o C with secondary antibody. To the three wells incubated with anti-Flag primary
antibody, Alexa fluor 647 conjugated goat anti-mouse IgG 2o Ab (Abcam) at 1:200
dilution was added. After 1 h incubation, cells were washed and incubated with 1:80
diluted anti-PRRSV FITC conjugated Ab (SDOW17) at 37o C for 1 h. The uninfected
vector control transfected well was incubated with Alexa fluor 647 2 o Ab only. The two
slides were washed, counterstained with DAPI, and then mounted as described
previously. The slides were then stored at 4 o C overnight and then observed using
Olympus Fluoview FV1200 Laser Scanning Confocal Microscope to study colocalization
of PRRSV and IFITM3 at 3 or 24 hpi. Briefly, five different microscopic fields at 40x
magnification were analyzed by confocal microscopy for each of the pQCXIP vector
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control transfected group and IFITM3-HA transfected group. In each field, cells were
counted by DAPI staining and then the percentage of cells staining for PRRSV (green) or
IFITM3 (red) was calculated. Colocalization study was performed by counting the
number of DAPI stained cells with yellow fluorescence which is observed due to overlap
of the emission spectra for green (FITC conjugated Ab for PRRSV N at 488 wavelength)
provided by Dr. Eric Nelson [98] and red (Alexa fluor 647 conjugated Ab for IFITM3)
(Abcam) dyes. Uninfected control cells stained with FITC conjugated anti-PRRSV Ab
were used as a control for comparing the background (green) staining with the PRRSV
infected group.
2.3.7 Cytotoxicity assay
MARC-145 cells cultured in a 96-well plate were transfected with either the
pQCXIP vector control or pQCXIP expressing IFITM3-HA or negative control siRNA
(Ambion, cat. no. AM4642) or IFITM3 siRNA (Life technologies, siRNA ID# s195035)
in triplicate wells, as described earlier. After 72 h, each well of the 96-well plate
incubated with 200 µl of DMEM growth medium was treated with 10 µl of CCK-8
solution (Sigma, cat. no. 96992) and incubated at 37 o C for 3 h, after which absorbance
was measured at 450 nm using a Synergy 2 plate reader (BioTek).
2.3.8 Real-time reverse transcription PCR (RT-PCR)
Total RNA extraction was done from cells harvested earlier using RNeasy
Mini Kit (Qiagen Cat. No. 74104), following the manufacturer’s protocol. To generate
cDNA, 1 µg of the total RNA extracted was reversed transcribed using High Capacity
cDNA Reverse Transcription Kit (applied biosystems) under following reaction
conditions: 25o C for 10 min, 37o C for 120 min, and 85o C for 5 min (Applied Biosystems
GeneAmp PCR System 2400). Real time PCR was performed by using 3 µl of the cDNA
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product as template for each reaction using Brilliant II SYBR Green QPCR master mix
(Agilent Technologies). Forty cycles of following conditions were used: 95 o C for 10 min,
95o C for 30 s, 55o C for 30 s, and 72o C for 30 s. Primers specific to beta-actin
housekeeping gene, PRRSV N, IFITM3, and Mx1 are shown in Table 2.1. The reactions
were run in a QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). Data
analysis was performed by calculating the mean fold change in gene expression using the
ΔΔCT method. Housekeeping gene beta-actin was used as a reference gene for
comparing the fold change between two treatment groups [88].
2.3.9 TCID 50 titer
Fifty-percent tissue culture infectious dose (TCID50 ) assay was performed
to determine the infectious PRRSV 23983 titer in the supernatant at 24 hpi obtained from
the previously described IFITM3 overexpression or siRNA induced knockdown
experiments. TCID50 titer was determined using the Spearman-Karber method [79].
2.3.10 Statistical analysis
A two tailed student’s t-test was used to compare the PRRSV titer between
pQCXIP vector control and IFITM3-HA transfected group. Likewise, relative fold
change in IFITM3 or PRRSV N mRNA gene expression was compared. Using t-test, the
mean fluorescent intensity was compared between vector control and IFITM3
overexpressing MARC-145 cells in both Amphotericin B treated and untreated group. In
all the statistical analysis, a p value less than 0.05 (p<0.05) was considered as significant.
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Table 2.1 Primer sequences of IFITM3, PRRSV N, and the house-keeping gene (betaactin).
Gene

Forward Primer (5’-3’)

Reverse Primer (5’-3’)

beta-actin

TTGCTGACAGGATGC

ACTCCTGCTTGCTGATCCACA

AGAAGGAGA

TCT

GGTCTTCGCTGGACAC

TGTCCCTAGACTTCACGGAGT

CAT

A

GTCAATCCAGACCGC

GATCAGGCGCACAGTATGAT

IFITM3

PRRSV N

CTTTA
Mx1

TTTTCAAGAAGGAGG

TCAGGAACTTCCGCTTGTCG

CCAGCAA

2.4 Results
2.4.1 Over-expression of IFITM3 reduces PRRSV replication
Western blotting analysis confirmed the expression of exogenous IFITM3 in cells
transfected with plasmid containing IFITM3-HA (Fig. 2.1 A), but not in cells transfected
with pQCXIP vector control (Fig. 2.1A). A slightly reduced expression of PRRSV N
protein was observed in cells expressing exogenous IFITM3 (Fig. 2.1A). Quantification
of the protein band intensity showed an average of 31% reduction in PRRSV N protein
expression in IFITM3 overexpressing cells as compared to vector control (Fig. 2.1B).
Virus titers in the supernatants of cells harvested at 24 hpi showed an average of 5.4-fold
decrease in IFITM3-HA transfected cells compared to vector controls (Fig. 2.1C).
Cytotoxicity assay showed that there were no significant differences in cell viability
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between vector control group and IFITM3 overexpressing group (Fig. 2.1D). The mean
absorbance values of vector control group and IFITM3 overexpressing group were 1.48
and 1.32 respectively (Fig. 2.1D). Taken together, these results suggest that
overexpression of IFITM3 protein reduces PRRSV replication.
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Fig. 2.1 Over-expression of IFITM3 reduces PRRSV replication. A: Representative
western blotting analysis showing the expression of exogenous IFITM3 in cells
transfected with plasmid containing IFITM3 (I), but not in cells transfected with vector
control (V). B: Quantitative analysis of the band intensity from western blot assay using
Image J. About 31% reduction in expression of PRRSV N protein is also observed in
cells expressing exogenous IFITM3 compared to vector control. C: Virus titers in the
supernatants of cells transfected with vector control or IFITM3 containing plasmid at 24
h after virus infection. An average of 5.4-fold decrease was observed in IFITM3
transfected cells compared to vector controls. D: CCK-8 cytotoxicity assay was used to
compare the difference in cell viability between pQCXIP vector control and IFITM3-HA
overexpressing MARC-145 cells at 450 nm. A p value < 0.05 was considered as
statistically significant.
2.4.2 Knockdown of IFITM3 by siRNA enhances PRRSV replication
To validate the knockdown of endogenous IFITM3, qRT-PCR was performed to
analyze the fold change in gene expression in IFITM3 silenced MARC-145 cells as
compared to control silencing RNA. qRT-PCR confirmed the silencing of IFITM3, with
an average of 50% knockdown efficiency (Fig. 2.2A). Furthermore, qRT-PCR was
performed to quantify the viral RNA copies in control silencing and IFITM3 silencing
RNA transfected cells. An average of 1.28-fold increase in viral RNA copies was
observed in IFITM3 silencing RNA transfected cells compared to control silencing RNA
transfected cells (Fig. 2.2B). There were no significant differences (p>0.05) in cell
viability between control silencing RNA and IFITM3 silencing RNA (Fig. 2.2C). The
mean absorbance values of negative control silencing group and IFITM3 silencing group
were 1.76 and 1.47 respectively (Fig. 2.2C). This shows that cytotoxicity does not play a
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role in IFITM3 mediated PRRSV restriction. Overall, knockdown of IFITM3 slightly
affected virus replication.
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Fig. 2.2 Knockdown of IFITM3 by siRNA enhances PRRSV replication. A: qRT-PCR
showing the silencing of IFITM3. B: qRT-PCR showing the viral RNA copies in control
silencing and IFITM3 silencing RNA transfected cells. An average of 1.28-fold increase
in viral RNA copies was observed in IFITM3 silencing RNA transfected cells compared
to control silencing RNA transfected cells. C: Difference in cell viability was compared
between the negative control siRNA and IFITM3 siRNA transfected MARC-145 cells.
Graph shows mean absorbance values read at 450 nm between the two groups. A p value
< 0.05 was considered as significant.
2.4.3 Positive correlation between interferon-induced IFITM3 upregulation and
reduced PRRSV replication
When compared to non-treated control group, PRRSV infection in MARC-145
cells upregulated the Mx1 gene expression but not IFITM3 (Fig. 2.3A). IFN-alpha
treatment induced mRNA gene expression of both IFITM3 and Mx1 as compared to the
control group (Fig. 2.3A). At 50 U/ml IFN-alpha concentration, the mean fold change in
IFITM3 gene expression as compared to IFN-alpha untreated cells was 1.94 (Fig. 2.3B).
At 100 U/ml concentration of IFN-alpha, the mean fold change in IFITM3 gene
expression was 3.73 (Fig. 2.3B). At 500 U/ml concentration of IFN-alpha, the mean fold
change in IFITM3 expression was 4.91 (Fig. 2.3B). As compared to the IFN-alpha
untreated group infected with PRRSV, the mean fold change in PRRSV N gene
transcripts upon treatment with IFN alpha at 50 U/ml, 100 U/ml, and 500 U/ml were
0.34, 0.16, and 0.07 respectively (Fig. 2.3B). These results demonstrate the dose
dependent response of IFITM3 upon IFN-alpha treatment and PRRSV replication in
MARC-145 cells is inversely correlated to the IFITM3 expression.
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Fig. 2.3 Positive correlation between interferon-induced IFITM3 upregulation and
reduced PRRSV replication. A: Relative fold changes in IFITM3 and Mx1 gene
expression in PRRSV 23983 infected groups when compared to mock treated groups are
shown. More abundant Mx1 as compared to IFITM3 mRNA is induced by IFN-alpha. B:
Real-time RT-PCR shows the relative fold changes of IFITM3 and PRRSV N mRNA
gene expression in IFN-alpha treated groups at different concentrations when compared
to non-treated control groups.

2.4.4 Amphotericin B treatment only partially restores PRRSV replication in
IFITM3 overexpressing MARC-145 cells
Immunofluorescence staining showed that IFITM3 overexpression significantly
reduced PRRSV infection in MARC-145 cells (Fig. 2.4A). To quantitatively estimate the
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PRRSV infection in the Amphotericin B treated and untreated group, flow cytometry was
performed. Analysis of virus-infected cells in the presence or absence of Amphotericin B
treatment confirmed that Amphotericin B only partially restored the replication of
PRRSV in cells over-expressing IFITM3 (Fig. 2.4B). In the Amphotericin B untreated
group, a significant reduction in mean fluorescence intensity (p < 0.05) in the IFITM3
overexpressing cells as compared to vector control was observed (Fig. 2.4B). This data
further validates our observation shown in Fig. 2.1
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Fig. 2.4 Amphotericin B treatment only partially restores PRRSV replication in IFITM3
overexpressing MARC-145 cells. A: Immunofluorescence staining of virus-infected cells
in the presence or absence of Amphotericin B treatment. Images were captured at 10x
magnification. B: flow cytometry analysis of virus-infected cells in the presence or
absence of Amphotericin B. * indicates p < 0.05 when compared to the pQCXIP +
PRRSV group.
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2.4.5 Colocalization of PRRSV with early endosome marker EEA1 at 3 hpi
To examine whether PPRSV enters the late endosomes during virus entry,
MARC-145 cells infected with PRRSV 23983 for 1 h, 3 h, or 6 h were stained for either
the early endosomal marker, EEA1 (Fig. 2.5A) or late endosome/lysosome marker,
LAMP-1 (Fig. 2.5C). The mean percent colocalization between PRRSV and EEA1 was
23.8%, 37.9%, and 31.8% at 1 hpi, 3 hpi, and 6 hpi respectively (Fig. 2.5B). However,
the mean percent colocalization with LAMP-1 was 5.7%, 11.6%, and 8% at 1 hpi, 3 hpi,
and 6 hpi respectively (Fig. 2.5D). At each time point, a greater percentage of
colocalization was observed between PRRSV and EEA1 than LAMP-1 (Fig. 2.5B, D).
Stronger colocalization between PRRSV and EEA1 was observed at 3 hpi (Fig. 2.5B). A
smaller percentage of colocalization between PRRSV and LAMP-1 was observed at 1
and 6 hpi as compared to 3 hpi (Fig 2.5D).
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Fig. 2.5 Colocalization of PRRSV with early endosome marker EEA1 at 3 hpi. A:
Colocalization of PRRSV with EEA1 at different time points. Tunneling nanotube-like
filamentous extensions were observed at 3 h after virus infection. B: Mean percent
colocalization was estimated using Image J. For each time point, mean percent
colocalization was calculated by randomly selecting five cells for each microscopic field.
Greater percentage of colocalization occurred with EEA1 at 3 hpi as compared to 1 or 6
hpi. C: Colocalization of PRRSV with LAMP-1 at different time points. D: Relatively
fewer colocalization between PRRSV and late endosome/lysosome marker LAMP-1 was
observed at 1 and 6 hpi as compared to 3 hpi. Images were captured using a confocal
microscope at 40x magnification.
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2.4.6 Over-expression of IFITM3 does not significantly impact virus entry
Cells over-expressing exogenous IFITM3 were stained for PRRSV at 3 and 24
hpi. Colocalization of IFITM3 with PRRSV was observed at both time points (Fig. 2.6A).
An average 73% of IFITM3 expressing cells contained virus at 3 hpi, while only
approximately 27% of IFITM3 expressing cells contained virus at 24 hpi (Fig. 2.6B).
Confocal images of control vector transfected cells showed clusters of virus-infected cells
at 24 hpi (data not shown), indicative of efficient cell-cell spread of virus. In contrast,
IFITM3 over-expressing cells typically showed a few punctuate positive virus staining
within isolated individual cells at 24 hpi (Fig. 2.6A).
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Fig. 2.6 Over-expression of IFITM3 does not significantly impact virus entry. A: Cells
over-expressing exogenous IFITM3 contains PRRSV at 3 and 24 hpi. Red: IFITM3;
Green: PRRSV N; Blue: DAPI. The colocalization of PRRSV with over-expressed
IFITM3 is shown. Images were taken at 40x magnification. B: The percentage of PRRSV
positive cells was significantly lower (p < 0.0001) in IFITM3 transfected cells at 24 hpi
than that of 3 hpi. Quantification was done by counting PRRSV positive cells and
IFITM3-HA expressing cells obtained from five different microscopic fields.
2.5 Discussion
IFITM3 is an interferon induced antiviral gene and partly contributes to the
antiviral effect of interferon. Indeed, IFITM3 has been shown to restrict the replication of
a diverse array of enveloped RNA viruses including PRRSV [39, 41, 112]. We have
shown here that over-expression of IFITM3 reduced PRRSV replication in MARC-145
cells, which is consistent with the previous observation made by others [153]. Similarly,
silencing of IFITM3 enhanced PRRSV replication as shown by both our study and
Zhang, et al. [153]. The observed virus replication enhancement effect in our study is
lower than what has been described in a previous study [153], which could be due to the
relatively low knockdown efficiency (an average of 50%) in our study. Collectively, both
overexpression and RNA silencing of IFITM3 data suggest its antiviral effect against
PRRSV.
IFITM3 is constitutively expressed in both MARC-145 cells and porcine alveolar
macrophages (PAMs). Our study and others [153] have shown the upregulation of
IFITM3 protein upon IFN-α treatment, which is positively correlated with reduced
PRRSV replication. PRRSV was shown to up-regulate IFITM3 gene expression in PAMs
at 24 hpi [153]. Interestingly, we observed that PRRSV infection reduced IFITM3 gene
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expression in MARC-145 cells at 24 hpi. This discrepancy in results could be due to the
different cell types used in each study.
It is generally believed that IFITM3 decreases membrane fluidity thereby
inhibiting virus-host cell membrane fusion and cytosolic release [104]. Studies using
single virus fusion assay have shown that IFITM3 restricts virus membrane fusion [31,
91]. One earlier study reported that PRRSV is associated with early endosome only and
not late endosomes [131]. We found that PRRSV colocalized with the early endosome
marker EEA1 at 3 hpi, but most disappeared from early endosome at 6 hpi. Relatively
fewer PRRSV colocalized with LAMP-1, a marker of late endosome and lysosome,
during the first 6 hpi. IFITM3 is known to restrict virus membrane fusion and trap virus
in late endosome for degradation [3, 138]. Amphotericin B treatment has been shown to
fully restore infection of many viruses that are restricted by IFITM3 [86, 91]. In a recent
study, Amphotericin B reversed the IFITM3 mediated entry-restriction of several
pseudovirus particles tested, including SARS-CoVpp and IAVpp, but not LASVpp [158].
Amphotericin B is an antifungal drug known to restore membrane fluidity thereby
reversing the effect of IFITM3 mediated virus restriction [86]. It forms leak ion channels
in the cell membrane and has also been shown to associate with cholesterol in lipid rafts
[138]. Our observation suggests that IFITM3 may restrict PRRSV in a mechanism
different from SARS-COV and IAV [158] since fewer viruses were detected in late
endosome. This observation is also consistent with our data showing that Amphotericin B
treatment only partially restores PRRSV replication. Recently, Zhang et al. has shown
that PRRSV colocalizes not only with early endosomes but also late
endosomes/lysosomes at different stages of virus trafficking [153]. The discrepancy in
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results could be due to different experimental conditions used in each study. Zhang et al.
has also shown that IFITM3 does not restrict PRRSV attachment, entry, and
internalization into endosomes, but inhibits virus membrane fusion via cholesterol
induction in cellular vesicles [153].
Suddala et al. showed that IFITM3 expressing cells are not infected by IAV at 12
hpi, but adjacent cells not expressing IFITM3 are infected, suggesting that this antiviral
activity of IFITM3 is not due to conditioned medium [124]. Our results showed that
IFITM3 expressing cells do contain PRRSV at both 3 and 24 hpi, suggesting that a
potential different mechanism mediates the antiviral activity to PRRSV than IAV.
Suddala et al. suggests that IFITM3 accumulation at the sites of virus fusion prevents
virus release into cytoplasm and replication [124]. We observed an average 73% of
IFITM3 expressing cell contained PRRSV at 3 hpi, indicating that over-expression of
IFITM3 has little effect on virus entry. However, at 24 hpi, only 27% of IFITM3
expressing cells contained PRRSV. Colocalization study showed that PRRSV in IFITM3
overexpressing MARC-145 cells exhibited a punctuated staining pattern in isolated
individual cells at 24 hpi, while vector control cells typically showed clusters of virus
positive cells (data not shown and Fig. 2.6A). These observations suggest that efficient
cell-cell spread of virus may be affected by over-expression of IFITM3, which has also
been shown by Zhang et al. [153]. Earlier studies have shown that PRRSV upregulates
the formation of tunneling nanotubes (TNTs) to facilitate the intercellular spread of
PRRSV [50]. Hence it is tempting to speculate that IFITM3 over-expression may affect
cellular spread of virus by limiting formation of TNTs. Further studies are needed to
uncover the impact of IFITM3 overexpression on formation of TNT upon PRRSV
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infection. Overall, our data support a role of IFITM3 in restricting PRRSV post-entry into
cells.
In conclusion, over-expression of IFITM3 reduced PRRSV infection in MARC145 cells and may restrict PRRSV at the post-entry step since Amphotericin B treatment
did not completely rescue PRRSV infection. Silencing of endogenous IFITM3 increased
PRRSV-N RNA copies. Furthermore, a positive correlation between reduced PRRSV
replication and interferon induced upregulation of IFITM3 was observed. Further study is
needed to better understand the mechanisms by which IFITM3 restricts PRRSV
replication in MARC-145 cells and porcine alveolar macrophages.
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3.1 Abstract
The transmembrane zinc metalloprotease, ZMPSTE24, works in cooperation with
interferon induced transmembrane protein 3 (IFITM3) to restrict entry of several
enveloped viruses. We investigated the role of ZMPSTE24 in porcine reproductive and
respiratory syndrome virus (PRRSV) replication. ZMPSTE24 overexpression
significantly reduced PRRSV replication in MARC-145 cells. Interestingly, knockdown
of endogenous ZMPSTE24 did not significantly impact virus replication. There was no
significant difference in the percentage of PRRSV positive cells and viral RNA copies at
3 hours post infection (hpi) between cells transfected with ZMPSTE24-FLAG and vector
control. Our results suggest that ZMPSTE24 overexpression may restrict PRRSV
replication at a post-entry step.

Key words: virus restriction factors, ZMPSTE24, Porcine Reproductive and Respiratory
Syndrome Virus (PRRSV)

62

3.2 Introduction
Restriction factors such as interferon stimulated genes (ISGs) inhibit viruses at
various stages of their life cycle [115]. Many enveloped viruses enter host cells by
receptor mediated endocytosis. Triggered by acidic pH within endosomes, the viral
fusion peptide undergoes conformational change and facilitates virus fusion with
endosome membrane and uncoating. Several pH sensitive viruses that depend on low pH
for fusion have been shown to be strongly inhibited by IFITM3 [121]. IFITM3 is
localized in the early or late endosomes and impedes virus-host membrane fusion,
thereby blocking release of the genome [6, 39]. The restriction factor ZMPSTE24 works
in cooperation with the IFITM3 protein to restrict entry of several enveloped viruses [43,
84, 123]. ZMPSTE24 acts as a downstream effector of IFITM3 [43, 84]. The ZMPSTE24
protein is constitutively expressed and localized to inner nuclear membrane [8]. It is
important in the processing of precursor prelamin A into lamin A in the nuclear lamina
[8]. Defect in ZMPSTE24 has been shown to enhance accumulation of prelamin A [40].
Currently, there are very limited studies exploring the mechanism by which it restricts
virus entry including its interaction with the IFITM proteins and IFITM independent
virus restriction.
PRRSV is an enveloped, positive sense, single stranded RNA virus belonging to
the family Arteriviridae within the order Nidovirales [90]. PRRSV causes severe
respiratory disease in young pigs and reproductive failure in sows [90]. Upon attachment
and internalization, PRRSV enters into the early endosome in clathrin-coated vesicles and
virus-endosome membrane fusion leads to virus uncoating [131, 156]. The role of
IFITM3 in restricting PRRSV replication has been recently reported [153]. However,
very little is known whether ZMPSTE24 also restricts PRRSV replication. In this present
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study, we investigated the role of ZMPSTE24 in PRRSV replication and examined
whether ZMPSTE24 restricts PRRSV entry into cells.
3.3 Materials and methods
3.3.1 Plasmid transfection
A 12-well plate was seeded with 2x105 cells per well of MARC-145 cells. The
plate was incubated at 37o C in a humidified chamber with 5% CO 2 for 24 h. After 24 h
incubation, the cells were washed with raw DMEM medium. In triplicate wells, cells
were transfected with 1.25 µg per well of either pCMV-3Tag-8 control vector or FLAGtagged ZMPSTE24 cloned into pCMV-3Tag-8 (ZMPSTE24-FLAG) plasmid [43] using
Lipofectamine 3000 Transfection Kit (Invitrogen) according to the manufacturer’s
protocol. The plasmids were kindly provided by Dr. Shitao Li. Briefly, each of the
plasmid DNA was diluted in raw DMEM medium with P3000 and mixed with
Lipofectamine 3000 reagent diluted in raw DMEM in 1:1 ratio. The transfection mix was
then incubated at room temperature for 20 min after which 200 µl of the DNA-lipid
complex was added dropwise to the respective wells. For transfection in a 24-well plate,
5x104 cells were seeded in each well and after 24 h incubation, transfected with 0.6 µg of
each of the plasmids following similar protocol. The plates were incubated at 37 o C for 6
h, then raw medium was removed and complete medium (DMEM with 10% FBS and 1%
penicillin-streptomycin) was added. The plate was incubated at 37 o C for 72 h and then
PRRSV 23983 was added to each well at an MOI of 1. Following incubation at 37 o C for
24 h, the cells were scraped and supernatant with cells was collected in 1.5 ml tubes.
Each tube was centrifuged at 13,000 rpm for 3 min. The supernatant was collected and
used in TCID50 assay while cell pellets were stored for western blotting. For
colocalization or cytotoxicity study, 0.3 µg of the respective plasmid DNA was used to
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transfect MARC-145 cells that were seeded at 1X104 cells per well in either the 8chamber slide (colocalization study) or 96-well plate (cytotoxicity assay) and then
incubated at 37o C for 72 h.
3.3.2 Silencing RNA (siRNA)
For siRNA induced knockdown study, MARC-145 cells cultured in a 12-well
plate were transfected with either negative control siRNA (Ambion, cat. no. AM4642) or
ZMPSTE24 siRNA (Life technologies, siRNA ID# s20067) at a final concentration of 30
nM per well in complete medium using Lipofectamine RNAi max reagent (Invitrogen)
according to the manufacturer’s protocol. Transfection with either negative control
siRNA or ZMPSTE24 siRNA was performed in triplicate wells. Briefly, the siRNA was
mixed with RNAi max reagent diluted in raw DMEM medium in 1:1 ratio. The mixture
was incubated at RT for 5 min after which 125 µl of the siRNA complex was added
dropwise to the respective wells with raw DMEM medium and then incubated at 37 o C for
6 h. Then the raw medium was replaced with complete DMEM medium and incubated
for 72 h. Next, the cells in each well of the 12-well plate were infected with PRRSV
23983 at an MOI of 1 for 24 h after which cells were scraped and harvested with
supernatant and stored at -80o C until used for further study. For cytotoxicity experiment,
1.2 µl of either negative control siRNA or ZMPSTE24 siRNA at 30 nM concentration
was used for transfection. In a 96-well plate, 25 µl of transfection mix was added
dropwise to the respective wells with raw DMEM medium and incubated at 37o C for 6 h
after which media was replaced with complete DMEM medium and incubated at 37 o C for
72 h.
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3.3.3 Western blotting
Cell pellets were resuspended with 60 µl cell lysis buffer (0.01M Tris-HCl pH 8,
0.14 M NaCl, 0.025% NaN 3 , 1% Triton x-100) treated with HaltT M protease and
phosphatase inhibitor cocktail (Thermo Scientific, catalog# 78441) at 1:100 dilution.
Each sample was vortexed for 15 s and then incubated for 1 h at 4 o C, with vortexing
every 15 min. Each tube was then spun at 13,000 rpm for 1 min after which the lysate
was transferred to a new tube. Each lysate sample was mixed with equal volume of 2x
western blot loading buffer treated with beta-mercaptoethanol at 1:50 dilution and 40 µl
was loaded in each well. The samples were then incubated at 95o C for 5 min. The gel was
run at 150 V for 1.5 h, then transferred to nitrocellulose membrane run at 100 V for 1 h
and blocked by incubating the plate with 10 ml of blocking buffer (5% milk powder in
1xPBST) at room temperature (RT) for 1 h with shaking. Then the membrane was
washed with 1x PBST three times for 5 min each with shaking at RT and incubated
overnight with shaking at 4o C with respective primary antibodies prepared in 5% milk
blocking buffer. Following primary antibodies were used: anti-Flag mouse monoclonal
1o Ab against flag tagged ZMPSTE24 (9A3) (Cell Signaling Technology, cat. no. 8146S)
at 1:1000 dilution, anti-PRRSV SR-30 1o monoclonal Ab (provided by Dr. Eric Nelson)
at 1:300 dilution, and mouse monoclonal anti-beta actin-Ab (Sigma-Aldrich, catalog#
A2228) at 1:5000 dilution. Next day, the membrane was washed with 1x PBST three
times and then incubated while shaking at RT in dark with Goat anti-Mouse IRDye®
conjugated 2o Ab (LI-COR, catalog# 926-32210) diluted to 1:5000 in 1x PBST. The
membrane was washed in 1x PBST and observed using LI-COR Odyssey Infrared
Imaging System. Quantification of the protein (band) intensity was performed using
Image J. Beta-actin house keeping gene was used to calculate relative fold change in

66

PRRSV N protein expression in ZMPSTE24 overexpressing cells as compared to vector
control cells.
3.3.4 Immunofluorescence staining and flow cytometry
Briefly, MARC-145 cells were transfected with either vector control pCMV3Tag-8 or FLAG-tagged ZMPSTE24 cloned into pCMV-3Tag-8 (ZMPSTE24-FLAG)
[43] in triplicate wells of a 24-well plate as described earlier. Then 72 h post transfection,
PRRSV 23983 was added at an MOI of 1 to all six wells in DMEM growth medium and
the plate was incubated at 37o C for 24 h. All wells were fixed with 80% acetone at RT for
20 min, followed by air drying. Then 350 µl per well of 1:80 diluted FITC conjugated
anti-PRRSV Ab specific to N protein (SDOW-17) (provided by Dr. Eric Nelson) was
added and incubated at 37o C for 1 h. Cells in each well were washed in 1x PBS and then
observed under immunofluorescence microscope. Next, cells in each well were scraped
in 500 µl PBS, analyzed by flow cytometry, and mean fluorescence intensity for FITC
staining was calculated. The images were captured at 10x magnification using an
Olympus IX70 Inverted-Microscope (Epi-fluorescence and phase contrast).
3.3.5 Immunofluorescence staining and confocal microscopy
In duplicate wells, cells were transfected with either vector control pCMV-3Tag-8
or ZMPSTE24-FLAG in two 8-chamber slides following the protocol as described
earlier. For 3 hpi study, PRRSV 23983 at an MOI of 4 was added to each well of the first
slide except one vector-control transfected well. For 24 hpi study, PRRSV 23983 at an
MOI of 1 was added to each well of the second slide. Then the two 8-chamber slides
were fixed in 3.8% formaldehyde for 10 min at RT followed by one wash in 1x PBS for 5
min. The cells in each well were then treated with 0.2% Triton x-100 diluted in 1x PBS
for permeabilization and incubated at RT for 10 min. Next, the cells were washed and
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incubated at RT for 30 min with 5% goat serum in PBS for blocking non-specific
antibody binding. After washing in 1x PBS, cells in each well were incubated overnight
at RT with primary antibody diluted in 5% goat serum. Mouse monoclonal anti-Flag
primary antibody against flag tagged ZMPSTE24 (9A3) (Cell Signaling Technology, cat.
no. 8146S) was added at 1:1600 dilution to all wells except the uninfected vector-control
transfected well to which 5% goat serum was added. Next day, the slides were washed
three times with 1x PBS and then incubated for 1 h at 37o C with the secondary antibody.
To the three wells incubated with anti-Flag primary antibody, Alexa fluor 647 conjugated
goat anti-mouse IgG 2o Ab (Abcam) at 1:200 dilution was added. After 1 h incubation,
anti-PRRSV FITC conjugated Ab (SDOW-17) at 1:80 dilution was added and cells were
incubated at 37o C for 1 h. The uninfected vector-control transfected well was incubated
with Alexafluor 647 2o Ab only. The slides were washed in 1x PBS, counterstained with
DAPI for 3 min, air dried and then mounted using ProLong Gold antifade mounting
reagent (Invitrogen). The slide was then stored at 4 o C overnight and then observed using
Olympus Fluoview FV1200 Laser Scanning Confocal Microscope to study colocalization
of PRRSV and ZMPSTE24 at 3 or 24 hpi. Briefly, five different microscopic fields at
40x magnification were analyzed by confocal microscopy for each vector control
transfected group and ZMPSTE24 transfected group at each time point. In each field,
cells were counted by DAPI staining and then the percentage of cells staining for PRRSV
(green) or ZMPSTE24 (red) was calculated. Colocalization study was performed by
counting the number of DAPI stained cells with yellow fluorescence which is observed
due to overlap of the emission spectra for green (FITC conjugated Ab for PRRSV N at
488 wavelength ) and red (Alexafluor 647 conjugated Ab for ZMPSTE24) dyes.
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Uninfected control cells stained with FITC conjugated anti-PRRSV Ab were used as a
control for comparing the background (green) staining to the PRRSV infected group. All
images were taken at 40x magnification.
3.3.6 Real-time reverse transcription PCR (RT-PCR)
Total RNA extraction was carried out from cells harvested as described earlier
using RNeasy Mini Kit (Qiagen Cat. No. 74104) according to the manufacturer’s
protocol. To generate cDNA, 1 µg of the total RNA extracted was reversed transcribed
using High Capacity cDNA Reverse Transcription Kit (applied biosystems) under
following reaction conditions: 25o C for 10 min, 37o C for 120 min, and 85o C for 5 min
(Applied Biosystems GeneAmp PCR System 2400). Real time PCR was performed by
using 3 µl of the cDNA product as a template for each reaction using Brilliant II SYBR
Green QPCR master mix (Agilent Technologies). Forty cycles of following conditions
were used: 95o C for 10 min, 95o C for 30 s, 55o C for 30 s, and 72o C for 30 s. Primers
specific to beta-actin housekeeping gene, PRRSV N and ZMPSTE24 are shown in Table
3.1. The reactions were run in a QuantStudio 6 Flex Real-Time PCR System (Applied
Biosystems). Data analysis was performed by calculating the mean fold change in gene
expression using the ΔΔCT method. House keeping gene beta-actin was used as a
reference gene for comparing the fold change between two treatment groups [88].
3.3.7 TCID 50 titer
Fifty-percent tissue culture infectious dose (TCID50 ) assay was performed to
determine the infectious PRRSV 23983 titer in the supernatant at 24 hpi obtained from
the previously described ZMPSTE24 overexpression or siRNA induced knockdown
experiments. TCID50 titer was determined using the Spearman-Karber method [79].
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3.3.8 Cytotoxicity assay
MARC-145 cells were seeded in a 96-well plate at 1x104 cells/well and incubated
at 37o C for 24 h. Then, cells were transfected with either the vector control pCMV-3Tag8 or ZMPSTE24-FLAG, or negative control siRNA (Ambion, cat. no. AM4642) or
ZMPSTE24 siRNA (Life technologies, siRNA ID# s20067) in triplicate wells, as
described earlier. Then 72 h post transfection, each well of the 96-well plate incubated
with 200 µl of DMEM growth medium was treated with 10 µl of CCK-8 solution (Sigma,
cat. no. 96992) and incubated at 37o C for 3 h, after which absorbance was measured at
450 nm using a Synergy 2 plate reader (BioTek).
3.3.9 Statistical analysis
Student’s t-test (two tailed) was used to compare the PRRSV titer between
ZMPSTE24 overexpressing cells and vector control transfected cells. Likewise, PRRSV
titer was compared between siRNA induced ZMPSTE24 silenced cells and control
siRNA silenced cells. Similarly, mean fluorescence intensity between the ZMPSTE24
overexpressing cells and vector control cells was compared. A p value<0.05 was
considered as statistically significant. Data are represented as mean of three independent
experiments ± standard deviation.

70

Table 3.1 Primer sequences of ZMPSTE24, PRRSV N and the housekeeping gene.
Gene

Forward Primer (FP) 5’-3’

Reverse Primer (RP) 5’-3’

beta-actin

TTGCTGACAGGATGCA

ACTCCTGCTTGCTGATCCACATC

GAAGGAGA

T

GAGGAAGAAGGGAACA

ATGGCCTAGTACAGCGAGTA

ZMPSTE24

GTGAA
PRRSV N

GTCAATCCAGACCGCCT

GATCAGGCGCACAGTATGAT

TTA

3.4 Results
3.4.1 Overexpression of ZMPSTE24 in MARC-145 cells reduces PRRSV replication
Western blot confirmed the expression of ZMPSTE24 protein in cells transfected
with pCMV-3Tag-8 plasmid expressing ZMPSTE24-FLAG but not in vector control
pCMV-3Tag-8 transfected cells (Fig. 3.1A). A lower level of expression of PRRSV N
protein was observed in ZMPSTE24 overexpressing cells as compared to the vector
control cells at 24 hpi (Fig. 3.1A). An average of 3% reduction in PRRSV N protein
expression in ZMPSTE24 overexpressing cells was confirmed by quantification of the
protein band intensity (Fig. 3.1B). TCID50 assay showed an average of 146-fold decrease
(2.16 log reduction) in virus titer in ZMPSTE24 overexpressing cells as compared to the
vector control transfected cells (Fig. 3.1C). Further, Immunofluorescence staining
showed fewer virus positive staining (green) in ZMPSTE24 overexpressing cells as
compared to the vector control transfected cells (Fig. 3.1D). A significant reduction in
mean fluorescence intensity (p<0.05) was observed in ZMPSTE24 overexpressing
MARC-145 cells as compared to the vector control cells at 24 hpi as confirmed by flow

71

cytometry (Fig. 3.1E). No significant difference in cell viability between vector control
and ZMPSTE24 containing plasmid transfected cells was observed at 72 h posttransfection as measured using CCK-8 cell viability assay (Fig. 3.1F). The mean
absorbance values of 1.64 and 1.55 were confirmed in vector control and ZMPSTE24
overexpressing cells respectively (Fig. 3.1F).
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Fig. 3.1 Over-expression of ZMPSTE24 in MARC-145 cells reduces PRRSV replication.
Standard deviation and mean of three replicates are shown for each graph. A: Western
blot analysis showing the expression of ZMPSTE24 in cells transfected with ZMPSTE24
expressing plasmid. Lanes 1-3 were transfected with pCMV-3Tag-8 vector control (V)
while wells 4-6 were transfected with pCMV-3Tag-ZMPSTE24-FLAG (Z). Beta-actin
was used as a loading control. The expression of PRRSV N protein is shown. B:
Quantification of the protein band intensity using Image J showed an average of 3%
reduction in PRRSV N protein expression in ZMPSTE24 overexpressing cells. C: Virus
titers in the supernatants of PRRSV infected cells at 24 hpi. * indicates p < 0.05. D:
Immunofluorescence staining of virus-infected cells at 24 hpi. Top panel shows the bright
field image and the lower panel shows PRRSV positive staining. E: Flow cytometry
analysis of virus-infected cells at 24 hpi. * indicates p < 0.05. F: CCK-8 assay was used
to compare cell viability between vector control and ZMPSTE24 containing plasmid
transfected cells. No significant difference (p > 0.05) was observed.
3.4.2 Silencing of endogenous ZMPSTE24 slightly affects PRRSV replication
An average of 74% knockdown of endogenous ZMPSTE24 gene was achieved, as
confirmed by RT-PCR (Fig. 3.2A). Further, RT-PCR showed an average of 1.2 fold
increase in PRRSV N gene transcript relative to the silencing control (Fig. 3.2B).
Surprisingly, virus titers in the supernatants of ZMPSTE24 knockdown cells showed a
slight decrease relative to control silenced cells. An average of 2.5 fold decrease in virus
titer was observed (Fig. 3.2C). There was no significant difference in cell viability
between negative control siRNA and ZMPSTE24 siRNA transfected groups (Fig. 3.2D).
CCK-8 cell viability assay gave mean absorbance values of 1.76 and 1.99 in negative
control siRNA and ZMPSTE24 siRNA induced silenced cells respectively (Fig. 3.2D).
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Fig. 3.2 Silencing of endogenous ZMPSTE24 slightly affects PRRSV replication.
Standard deviation and mean of three replicates are shown for each graph. A: qRT-PCR
showed an average ZMPSTE24 knockdown efficiency of 74%. B: The relative fold
change in viral RNA copies in ZMPSTE24 siRNA transfected cells compared to control
silencing RNA transfected cells. No significant difference (p > 0.05) was observed
between the two groups. C: TCID50 assay showing virus titers in the supernatants of
ZMPSTE24 silencing cells as compared to the control silencing cells. No significant
difference between the two groups was observed (p > 0.05). D: Cell viability was not
significantly (p > 0.05) affected by the transient silencing of ZMPSTE24.
3.4.3 Over-expression of ZMPSTE24 does not affect PRRSV entry into MARC-145
cells
There were no significant differences in the number of PRRSV positive cells or
total viral RNA copies between the vector control and ZMPSTE24 over-expressing cells
at 3 hpi (Fig. 3.3A, B). RT-PCR showed 900 fold change in ZMPSTE24 mRNA
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transcript in ZMPSTE24 overexpressing MARC-145 cells as compared to vector control
transfected cells, confirming the successful transfection and over-expression of
ZMPSTE24 (Fig. 3.3C). Extensive colocalization between PRRSV and ZMPSTE24 was
observed at 3 hpi. However, little or no colocalization was observed at 24 hpi (Fig. 3.3D).
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Fig. 3.3 Over-expression of ZMPSTE24 does not affect PRRSV entry into MARC-145
cells. A: Quantitative analysis of PRRSV positive cells in ZMPSTE24 expressing cells
and vector control cells at 3 hpi. Percentage of PRRSV positive cells was determined by
dividing the green (FITC-SDOW-17) staining cells by total number of cells (DAPI
stained, blue) in each microscopic field. The average and standard deviations of five
different microscopic fields are shown. The percentage of red staining (Alexa 647,
ZMPSTE24 expressing cells) that is positive for PRRSV was determined similarly. Red
and green co-staining cells were counted and divided by the total number of red staining
cells. No significant difference (p > 0.05) was observed between vector control and
ZMPSTE24 transfected group. B: The relative fold change in viral RNA copies in
ZMPSTE24 transfected cells when compared to vector control at 3 hpi as determined by
qRT-PCR. Standard deviation and mean of three replicates are shown. C: qRT-PCR
showing the relative fold increase in ZMPSTE24 mRNA level in ZMPSTE24 transfected
cells compared to vector control cells. Standard deviation and mean of three replicates are
shown. D: Colocalization of PRRSV N protein with exogenous ZMPSTE24.
Representative images show the extensive colocalization of PRRSV N with ZMPSTE24
at 3 hpi and little or no colocalization of PRRSV N protein with ZMPSTE24 at 24 hpi.
Green: PRRSV N protein. Red: Flag-tagged ZMPSTE24. Blue: DAPI nuclei.
3.5 Discussion
ZMPSTE24 overexpression has been shown to significantly reduce influenza A
virus (IAV) infection in A549 cells [43]. Interestingly, in the same study, although
ZMPSTE24 inhibited several RNA and DNA viruses requiring pH dependent fusion, it
failed to inhibit murine leukemia virus [43]. To investigate the effect of ZMPSTE24 on
PRRSV replication, we first employed the ZMPSTE24 overexpression system. In our
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study, we confirmed reduced expression of PRRSV N protein as well as reduced virus
titer in ZMPSTE24 overexpressing cells. Further, cell viability did not play a role in
ZMPSTE24 mediated PRRSV restriction. To further confirm the role of ZMPSTE24 in
restricting PRRSV replication, we employed silencing RNA mediated knockdown of
endogenous ZMPSTE24 approach. The PRRSV N gene transcripts were only slightly
higher in ZMPSTE24 silenced cells relative to silencing control. Overall, our results
showed that silencing of endogenous ZMPSTE24 does not appear to have a significant
impact on PRRSV replication. This observation could be due to the knockdown
efficiency (74%) achieved in our hands, while previous studies used cells derived from
gene knockout animals [43]. Additionally, it is possible that transient silencing of
ZMPSTE24 may not mimic the cells from gene knockout mice [43, 77]. Taken together,
both overexpression and RNA silencing of ZMPSTE24 data suggest its antiviral effect
against PRRSV.
Previous studies showed that ZMPSTE24 and IFITM3 work together to block
entry of various enveloped viruses including IAV and arenaviruses [43, 123]. In this
study, we investigated if overexpression of ZMPSTE24 restricts PRRSV entry. There
were no significant differences (p > 0.05) in the number of PRRSV positive cells or total
viral RNA copies between the vector control and ZMPSTE24 over-expressing cells at 3
hpi. Our results are in indirect contrast to an earlier study which showed a dramatic lower
number of IAV virus positive cells compared to the vector control as early as 2 hpi and
persisted until 8 hpi [43]. This difference could be due to different virus entry
mechanisms or distinctive replication efficiency of each virus in the respective cell
culture model systems.

77

PRRSV completes one infectious cycle in about 8 h [153]. We observed that
PRRSV more significantly colocalized with the early endosome marker EEA1 at 3 hpi,
but most disappeared from early endosome at 6 hpi (data not shown). Relatively fewer
PRRSV colocalized with LAMP-1, a marker of late endosome/lysosome, during the first
6 hpi. One previous study showed colocalization of PRRSV with EEA1 but not with the
late endosomal marker [131]. However, a more recent study showed colocalization of
PRRSV with late endosome marker [153]. Therefore, the existing data remain
controversial regarding whether PRRSV enters cells through late endosomes. We
observed extensive colocalization between ZMPSTE24 and PRRSV at 3 hpi, suggesting
virus entry into early endosomes was not disturbed by ZMPSTE24 overexpression.
However, little or no colocalization between PRRSV and ZMPSTE24 was observed at 24
hpi, suggesting that restriction of PRRSV replication in cells with ZMPSTE24
overexpression likely occurred after 3 hpi. It is known that IFITM3 and ZMPSTE24 work
together to trap enveloped virus in the endolysosomal compartment for degradation [43,
84]. Future studies on colocalization of PRRSV with late endosome/lysosome marker
(LAMP-1) in ZMPSTE24 overexpressing cells may reveal more information on whether
PRRSV is also being degraded in late endosome/lysosome.
We observed a difference in the morphology of virus infected cells between the
cells not expressing ZMPSTE24 and the cells over-expressing ZMPSTE24. Specifically,
an increased number of cell surface protrusions were observed in the vector control group
at 3 hpi (data not shown). One possible explanation is that ZMPSTE24 overexpression
may suppress the formation of cell surface protrusions mediated by small GTPase such as
Rho [50, 75, 101]. Future investigation may clarify if ZMPSTE24 also interferes with

78

PRRSV intercellular spread. Overall, the data suggest that overexpression of ZMPSTE24
does not significantly impact virus entry and may limit virus replication via a post-entry
step. Although ZMPSTE24 inhibited several RNA and DNA viruses requiring pH
dependent fusion, it failed to inhibit murine leukemia virus [43]. Alternatively,
ZMPSTE24 may also bind to other substrates for its antiviral activity [84]. The detailed
mechanism by which overexpression of ZMPSTE24 restricts PRRSV replication needs to
be examined in future studies.
In conclusion, overexpression of ZMPSTE24 reduced PRRSV infection in
MARC-145 cells. There was no significant difference in the percentage of cells positive
for PRRSV and viral RNA copies in ZMPSTE24 overexpressing cells as compared to the
vector control cells at 3 hpi. This suggests that ZMPSTE24 may inhibit PRRSV at a postentry step. The role of endogenous ZMPSTE24 in PRRSV replication seems to be limited
in our experimental model system and needs to be investigated further in future studies.
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Chapter 4: Conclusions and Future directions
In this study, the role of IFITM3 on PRRSV replication was studied. Our
overexpression experiments support the antiviral role of IFITM3 against PRRSV.
Surprisingly, siRNA induced silencing of endogenous IFITM3 in MARC-145 cells only
showed a slight enhancement on PRRSV replication. However, a recent study showed
significant enhancement of PRRSV infection upon silencing of endogenous IFITM3
[153]. The discrepancy in results could be due to different knockdown efficiency since
we only achieved an average of 50% knockdown under our experimental conditions. The
antiviral role of ZMPSTE24, a downstream effector of IFITM3, was also studied. Our
study showed that ZMPSTE24, like IFITM3, exerts antiviral effect against PRRSV.
However, silencing of ZMPSTE24 at a knockdown efficiency of 74% showed only slight
effect on PRRSV replication. In an earlier study, ZMPSTE24 knockout mouse embryonic
fibroblasts (MEFs) were shown to be highly susceptible to Influenza A virus (IAV)
infection. The transient silencing of ZMPSTE24 in our study may be one of the factors
contributing to the limited effect of silencing ZMPSTE24 on PRRSV restriction. Taken
together, the results from our study suggest that the endogenous proteins-IFITM3 and
ZMPSTE24 only play a small role in PRRSV replication under the experimental
conditions used in our study.
The viruses that enter into host cells via late endosomes and are pH dependent are
shown to be restricted by IFITM3 at the virus entry step. Amphotericin B treatment can
fully restore virus replication. Earlier study showed that PRRSV requires trafficking
through early endosomes only [131]. However, a recent study suggests that PRRSV is
trafficked into IFITM3 containing endosomes and lysosomes [153]. Zhang et al. further
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showed that cholesterol accumulation blocks virus membrane fusion. Our results also
suggest that PRRSV is trafficked to late endosomes, even though greater percentage of
colocalization occurred with early endosomes (at 3 hpi) than with late endosomes.
Consistent with this observation, it is interesting that Amphotericin B only partially
restored PRRSV replication in our study. Further, our study suggested that PRRSV was
more significantly inhibited after 3 hpi. PRRSV was detected in IFITM3 overexpressing
cells at both 3 and 24 hpi, suggesting that IFITM3 did not completely restrict virus entry
and replication. Previous study has shown that ZMPSTE24 impedes IAV endosomal
entry [43]. In our study, while little or no colocalization between PRRSV and
ZMPSTE24 was observed at 24 hpi, significant colocalization was observed at 3 hpi.
There was no significant difference in the percentage of PRRSV positive cells between
vector control and ZMPSTE24 overexpressing cells at 3 hpi. Collectively, these findings
suggest that IFITM3 and ZMPSTE24 likely restrict PRRSV at multiple post-entry steps.
ZMPSTE24 and IFITM3 work together to impede virus-host membrane fusion
primarily in the late endosomes. In future, it will be important to investigate if PRRSV is
also trapped in the endolysosomes for degradation. Studying colocalization of PRRSV
with late endosome marker in ZMPSTE24 overexpressing cells may reveal more on this.
The restriction factor, ZMPSTE24 was proposed to be a downstream effector of IFITM3
protein and was shown to be important in the IFITM3 mediated restriction of IAV [43]. It
may be useful to test if knockdown of IFITM3 affects endosomal recruitment of
ZMPSTE24 and not vice versa. However, ZMPSTE24 may also restrict PRRSV by
IFITM3 independent mechanisms. In our study, we showed that the restriction factorsIFITM3 and ZMPSTE24 individually restrict PRRSV replication in vitro. In future, it
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may be important to investigate the cooperative antiviral activity of IFITM3 and
ZMSPTE24 against PRRSV. For instance, the synergistic effect of IFITM3 and
ZMPSTE24 against PRRSV replication could be investigated. Interestingly, a recent
study on arenaviruses, known to be relatively resistant to the effect of IFITM3, showed
that ZMPSTE24 overexpression causes redistribution of IFITM3 to distinct endosomal
compartments, such as early endosomes [123]. Overall, these findings may have
important implication in the context of PRRSV restriction and needs further study.
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